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Executive Summary 
In November 2017, the European Commission issued a Communication ‘Setting out the EU approach to 
Standard Essential Patents’1 in which it calls for increasing transparency on SEP2 exposure. In 2020, the 
European Commission published a commissioned report3 that aims to evaluate the technical and 
institutional feasibility of performing large-scale essentiality checks of patents, titled ‘Pilot project for 
essentiality checks of Standard Essential Patents’. 
This study is a companion to the above report. Since patents disclosed at Standards Developing 
Organisations (SDOs) may be a starting point of such essentiality analyses, this study aims to (1) provide 
a patent landscape analysis of SDO disclosed patents (and what this implies for their use as input to an 
essentiality assessment mechanism) and (2) analyse whether SDO disclosed patents differ from 
comparable other patents in quality (both technical merit and economic value). This study focuses on 
patents disclosed to the European Telecommunications Standards Institute (ETSI), This SDO is not only 
very important in the field of telecommunications, but also maintains one of the best databases of such 
disclosures to date.  
The findings of our study are as follows: 
1. It is a non-trivial task to identify patents from an SDO disclosure database and clean/ 
harmonize/select/de-duplicate/transform that data into information to be used for a given 
purpose, such as input for a process of essentiality assessment. Also important is a good 
understanding of both the SDO’s IPR policy, the related procedures, and database aspects. This 
study provides guidance for people than want to analyse SDO databases. 
2. Disclosed patents at SDOs are self-reported by companies on the basis of their belief that these 
patents “may be or may become essential”. This has important implication for what this data 
means, for what purpose it is fit to use and for which purpose it is not. Please refer to Figure 14, 
on page 28, for an overview of the inherent limitations of this type of data. 
3. ETSI-disclosed patents can be used as a starting point for an essentiality assessment procedure. 
For a full assessment (e.g. not sampling). a total of 8,320 to 11,262 (granted) patents would 
need to be assessed, dependent on the geographical scope of the SEPs exposure to be examined. 
Note that this is only for ETSI disclosures, and that, on a weekly basis, new disclosures are added.  
4. In a given patent family, some patents may be actually essentials, while others may not. We 
strongly recommend taking the ETSI family definition as a starting point, as it is the best way to 
identify family members of disclosed patents that may indeed also be essential. Other family 
definitions (e.g. DOCDB and INPADOC) are problematic in that respect.  
5. There is strong upwards trend in the number of new patent families being disclosed. Of all current 
25,072 families in the ETSI disclosure database, 37% were added in just the last two years. 
6. We observe considerable fragmentation in the distribution of companies – or organisations – that 
disclosed these patents and observe that the distribution is also very skewed. Such distributional 
characteristics have to be taken into account should any essentiality assessment scheme consider 
the use of sampling.  
7. We observe big shifts over time in terms of the home country of firms disclosing patents. 
Especially remarkable is the recent increase in shares of disclosed patent families from Chinese 
firms and, to a lesser degree, from South Korean firms, at the expense of European and US firms. 
8. While it would be desirable to break ETSI disclosures related to cellular standards up into, for 
instance, technology generations (2G, 3G, 4G and 5G), this is currently not possible in a reliable 
way. This is, among other things, related to the way 3GPP technical specifications series (which 
are the input to ETSI standards and specification) are structured. 
9. We find that disclosed SEPs score higher than comparable, non-disclosed patents on common 
proxies associated with patent quality, in terms of technical merit of patents, as well as economic 
value of patents. In this study, we offer an interpretation of that result.  
                                                        
1 European Commission (2017). 
2 SEP: Standard Essential Patent. 
3 Bekkers et al. (2020). 
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1 Introduction 
In November 2017, the European Commission issued a Communication ‘Setting out the EU approach to 
Standard Essential Patents’ (European Commission, 2017) in which it calls for increasing transparency on 
SEPs exposure. In March 2020, the European Commission published a commissioned report that aims to 
evaluate the technical and institutional feasibility of performing large-scale essentiality checks of patents, 
titled ‘Pilot project for essentiality checks of Standard Essential Patents’ (Bekkers et al., 2020).  
This study is a companion to the above report. The main goals of this study are:  
 To provide a patent landscape analysis of SDO disclosed patents (and what this implies for their 
use as input to an essentiality assessment mechanism)  
 To analyse whether SDO disclosed patents differ from comparable other patents in quality (both 
technical merit and economic value). 
Before we go into detail, it is important to stress that the starting point for this study is data that is self-
reported by companies on the basis of their belief that these patents ‘may be or may become essential 
to an ETSI standard’ (see Section 2.1). This has important implication for what this data means, for 
what purpose it is fit to use and for which purpose it is not. Please see Figure 14, on page 28, for more 
details. 
1.1 Approach and challenges  
Over the last decade, a lot of studies have analysed the lists of patents that are disclosed as essential or 
potentially essential, and many of them also investigated features of these patents such as forward 
citations (Bekkers et al., 2017). To learn how disclosed SEPs possibly differ from other patents, one needs 
to compare these with patents that are not disclosed but otherwise comparable. There are several 
challenges here. This chapter describes the methodology we adopted to tackle these challenges and the 
results of an extensive comparison in terms of patent quality measures between disclosed SEPs and a 
group of suitable control patents. 
The first challenge one needs to deal with for this type of study is to identify a reliable source for 
disclosure data, a source that would allow to identify the universe of disclosed patents for a specific 
standard and to clearly identify all the members of the patent family of the disclosed patents. These are 
necessary requirements for reducing concerns of confounding effects in the analysis. Using a data source 
that is not complete or does not permit to reconstruct the full patent family of a disclosed patent would 
expose the analysis to the risk of including patents that have been disclosed as SEPs or members of a 
family disclosed as SEP. To ensure our analysis met the above requirements, we decided to focus on 
patents disclosed to a single Standard setting Organization (SSO): the European Telecommunication 
Standardization Institute (ETSI). ETSI maintains a public and complete database of patents that are 
disclosed by the patent owners as potentially essential to an ETSI standard. The information available in 
the ETSI database also allows to reconstruct the patent family of disclosed patents and to match the 
disclosed SEPs to other data sources to recover additional bibliographic information.  
Second, although the ETSI database is public, the data collection and processing require considerable 
attention and careful decision making. We aimed at creating a list of all the unique patents and patent 
applications disclosed to ETSI and to identify all the members of the family of the disclosed patents. To 
this end, we decided to follow the definition of patent family used by ETSI itself, which includes all the 
documents having at least one priority in common, including the priority document(s) themselves. In 
addition, we also decided to consider both granted patents and patent applications in our data gathering 
and identification process. For this reason, unless in the cases in which we clearly indicate otherwise, 
whenever we speak of ‘patents’ in this study, we mean both patent and patent applications (similar to the 
ETSI IPR policy).4 
                                                        
4  As we will explain later, some parties also disclosed USPTO provisional patent applications to ETSI. These disclosed patents are 
not harmonized by ETSI, neither part of the PATSTAT database, and not included in our analysis. Yet, in many cases, if this 
provisional patent application was the basis of a later real patent application, the patent owner has disclosed that application 
and thus would be in our analysis. 
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Third, we need to gather additional and up-to-date information about the ETSI disclosed patents. To do so, 
we matched the list of disclosed SEPs that we recovered from ETSI with patents in EPO’s Worldwide 
Patent Statistical Database PATSTAT (Version 2018b). Of particular importance is the identification and 
construction of the patent quality measures that are used for the focal analysis.  
Finally, the quality comparison between disclosed SEPs and ‘comparable’ patents not disclosed as SEP 
demanded the creation of an appropriate control set. To facilitate this task, we decided to consider 
exclusively patents granted by the USPTO or the EPO, clearly both for the disclosed SEPs and the control 
patents. Then we apply exact matching technique to increase the degree of similarity of between the two 
groups, and, given the general abundance of potential control patents for each disclosed SEP, we randomly 
select up to five control patents for each of the treated unit.  
This study is structured as follow: Chapter 2 discusses the data collection and processing; Chapter 3 
describes the matching with the PATSTAT database, the construction of our variables of interests, and 
present descriptive statistics about the patent actually disclosed to ETSI; Chapter 4 describes the creation 
of the control group, the method of analysis and presents the results. Chapter 5 concludes. Table 1 reports 
a brief description of the content, data, and methodology used in each in each of the sections. 
Table 1. Overview of chapters: Content, data, and methodology 
Chapter and main topics Data Method Outcome 
2.Data collection: 
- Identification of disclosed 
SEPs 
- Identification of the ETSI 
patent family 
ETSI on-line disclosure 
database 
EPO-PATSTAT Database 
(Autumn, 2018) 
Database matching based on 
application/publication number 
or family identifier 
Identification of 25,072 
disclosed (basis) patents and 
their related ETSI family 
3. Disclosed SEP landscape: 
- Construction of relevant 
patent variables (patent 
level) 
- Descriptive statistics 
25,072 disclosed (basis) 
patents as identified in 
Chapter 2  
 
Gathering of patent level 
information on the sample of 
25,072 disclosed (basis) 
patents 
Patent-level information 
dataset 
Description of the 
characteristics of 
disclosed (basis) patents 
along several dimensions: 
timing, technology, 
ownership, patent family 
size, claims, and backward 
and forward citations  
4. Quality assessment: 
- Identification of the 
disclosed SEP  
- Construction of the 
control set 
- Quality assessment  
Set 1: 4,607 granted 
disclosed EPO patents 
and 19,477 matched 
control patents 
Set 2: 12,832 granted 
disclosed USPTO patents 
and 56,100 matched 
control patents 
EPO-PATSTAT Database 
(Autumn, 2018) 
OECD Quality Database 
(Version 2019) 
Starting point is the 25,072 
patent families, as identified in 
Chapter 2. 
Focal patents are granted EPO 
(USPTO) patent family 
members of these families 
Construction of the control 
group: exact matching on 
patent-level characteristics  
 
Quality comparison between 
disclosed SEPs and patents 
not disclosed  
Regression analysis to 
account for quality 
differences between 
disclosed and control 
patents 
 
  
 
5 
1.2 Terminology 
In terms of terminology, we stay close to the way terms are defined by ETSI.5In particular:  
 By ‘patent’ we refer to patents, utility models, and applications therefor. 
 By ‘basis patent’, we mean a patent disclosed to ETSI as potentially essential, including its patent 
family (according the ETSI patent family definition).6  
 By ‘Patent family according to the ETSI patent definition’, we mean all the patent documents 
having at least one priority in common, including the priority document(s) themselves. 
 Following the terminology in the ETSI database, by disclosing ‘company’ or ‘firm’, we refer to any 
organization that discloses a patent, including public and private research organisations, 
associations, and universities.  
 In the field of essential patents, both the word ‘disclose / disclosure’ and ‘declare / declaration’ is 
used when a party informs an SDO of a patent that may be essential. Also in ETSI’s documents, 
both terms are used. In the context of this study, the terms are exchangeable. For reasons of 
consistency, we use the word ‘disclose’ and ‘disclosure’, unless when we refer to the specific 
wording used in sources. 
                                                        
5  For the ETSI definitions, see Clause 15 of the ETSI Intellectual Property Rights Policy, in Annex 6 of ETSI (2018a). 
6  The term ‘basis’ is used by ETSI itself in its IPR database; see ETSI (2011). 
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2 Data collection 
2.1 The ETSI IPR disclosure database 
The European Telecommunication Standardization Institute (ETSI) maintains a public database of patents 
(as well as patent applications and business models7) that are disclosed by their owners8 in the belief that 
these patents may be or may become essential to an ETSI standard.9 As a result, this database contains 
patents that are potentially essential. In the disclosure form, owners can also indicate that they are willing 
to commit to license these essential IPR at FRAND terms and conditions, to the extent that these patents 
actually become essential10 (which they almost invariable do). Only the declarant can modify its own 
declaration11; ETSI is not entitled to modify a declaration. 
The purpose of this database (and the related disclosure) is, in short, that ETSI knows what patents are 
potentially essential, and knows for which patents a license commitment is provided. Should a license 
commitment not be provided for a potentially essential patent, then ETSI can avoid adopting a standard 
that would require the use of that patent.12 
It is important once more to stress that the patents in this database are potentially essentially, and not 
necessarily actually essential. 
2.2 Patent families and the ETSI disclosure database  
It is common that an applicant files for patents on the same invention in multiple jurisdictions. An ETSI 
member may (voluntary) disclose all or a multiple of these patents, or just disclose one of them. Yet, to 
ensure that a FRAND licensing commitment still covers all these patents, ETSI specifies that the licensing 
commitment is deemed to be made for all existing and future members of the patent family of that 
patent family.13 An important aspect here is to define what a patent family exactly means in then ETSI 
context. But before doing so, we first shortly discuss two other common patent family definitions, known 
as the DOCDB family and the INPADOC family, used by the European Patent Office, and others.  
                                                        
7 The ETSI IPR policy covers IPR, which are defined as “any intellectual property right conferred by statute law including 
applications therefor other than trademarks. For the avoidance of doubt rights relating to get-up, confidential information, trade 
secrets or the like are excluded from the definition of IPR.” Furthermore, a “Patent family” in ETSI is defined as “all the 
documents having at least one priority in common, including the priority document(s) themselves. For the avoidance of doubt, 
“documents” refers to patents, utility models, and applications therefor.” ETSI Intellectual Property Rights Policy, Clause 15, in 
Annex 6 of ETSI (2018a). In the context of this study, patents, patent applications and business models are the most relevant 
(there are very few, if any other IPR disclosed to ETSI). In this study, when we refer to ‘patents’, we mean patents, patent 
applications and business models. 
8  While at ETSI a party can also disclose a patent owner by another party (i.e. by mentioning it at a meeting, or informing ETSI by 
letter), the disclosures as we find them in the ETSI IPR database are also licensing commitments and are submitted by the 
patent owner. 
9  The precise language in the ETSI ‘Information Statement and Licensing Declaration” (ISDL) via which such disclosures are 
submitted is: “In accordance with Clause 4.1 of the ETSI IPR Policy the Declarant and/or its AFFILIATES hereby informs ETSI that 
it is the Declarant’s and/or its AFFILIATES’ present belief that the IPR(s) disclosed in the attached IPR Information Statement 
Annex may be or may become ESSENTIAL in relation to at least the ETSI Work Item(s), STANDARD(S) and/or TECHNICAL 
SPECIFICATION(S) identified in the attached IPR Information Statement Annex.” The referred Clause §4.1 reads as follows: 
“Subject to Clause 4.2 below, each MEMBER shall use its reasonable endeavours, in particular during the development of a 
STANDARD or TECHNICAL SPECIFICATION where it participates, to inform ETSI of ESSENTIAL IPRs in a timely fashion. In 
particular, a MEMBER submitting a technical proposal for a STANDARD or TECHNICAL SPECIFICATION shall, on a bona fide basis, 
draw the attention of ETSI to any of that MEMBER's IPR which might be ESSENTIAL if that proposal is adopted.”. ETSI Intellectual 
Property Rights Policy, in Annex 6 of ETSI (2018a). 
10  The patent owner may also make its commitment subject to the condition that those who seek licensees agree to reciprocate. 
See Clause 6.1, ETSI Intellectual Property Rights Policy, in Annex 6 of ETSI (2018a). 
11  Note, however that while updates are allowed, a licensing commitment entered into is irrevocable. See Clause 6.1, ETSI 
Intellectual Property Rights Policy, in Annex 6 of ETSI (2018a). 
12  The overall purpose of the ETSI IPR policy is as follows: “to reduce the risk to ETSI, MEMBERS, and others applying ETSI 
STANDARDS and TECHNICAL SPECIFICATIONS, that investment in the preparation, adoption and application of STANDARDS could 
be wasted as a result of an ESSENTIAL IPR for a STANDARD or TECHNICAL SPECIFICATION being unavailable.”. Clause 1, ETSI 
Intellectual Property Rights Policy, in Annex 6 of ETSI (2018a). 
13  “The obligations pursuant to Clause 4.1 above are deemed to be fulfilled in respect of all existing and future members of a 
PATENT FAMILY if ETSI has been informed of a member of this PATENT FAMILY in a timely fashion. Information on other 
members of this PATENT FAMILY, if any, may be voluntarily provided.” ETSI Intellectual Property Rights Policy, Clause 4.3, in 
Annex 6 of ETSI (2018a). 
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To better understand the various patent family definitions and their implications, we will use an example 
of eight patents. A key element here are the priority documents that can be listed in patent applications. 
The presence of a priority document indicates that (some) elements of the application are already part of 
an earlier application, and that the examiner should use the data of that priority document in order to 
determine the relevant prior art when examining that patent. This might be the case if an application for 
the same invention has already been filed abroad,14 but it is also possible if an application builds upon an 
element already present in another application filed in the same country, or, in the US, on a provisional 
patent application.  
Now, for our example, assume that our eight patents that have the following priority relationships: 
 Patent A lists no priority documents. We will call the invention in this patent Priority 1 (PRI1) 
 Patent B lists Patent 1 as a priority. It also adds some novel elements; which we will call 
Priority 2. 
 Patent C lists Patent 2 as a priority. It also adds some novel elements; which we will call 
Priority 3. 
 Patent D lists both Patent 2 and Patent 3 as priorities. It does not add any new elements (for 
instance, it could be the same patent application text as Patent C but filed in another country).  
 Patent E lists Patent 3 as a priority. It also adds some novel elements; which we will call Priority 4. 
 Patent F lists Patent 5 as a priority. It also adds some novel elements; which we will call Priority 5. 
 Patent G lists Patent 6 as a priority. It does not add any new elements (for instance, it could be 
the same patent application text as Patent F but filed in another country).  
 Patent H lists Patent 6 as a priority. It does not add any new elements (for instance, it could be 
the same patent application text as Patent F but filed in another country).  
Figure 1 now shows our eight patents, where the arrows represent the priorities listed by the patents, and 
the underlying priorities elements (which consist of one or more patent claims) are shown as PRI1 thru 
PRI5.  
Figure 1 Example of eight patents and their priority relationships 
 
 
                                                        
14  Under the right of priority, established by the Paris Convention for the Protection of Industrial Property of 1883, an applicant 
that filed for a patent one country can within 12 months, apply for protection for that invention in all the other countries. These 
later applications will then be regarded as if they had been filed on the same day as the earliest application. Via the so-called 
PCT route, the applicant has additional possibilities, even after 12 months. See WIPO (2008) for more details (especially §5.20, 
§5.252).  
`
PRI1Patent A
Patent B
Patent C
Patent D
Patent E
Patent F
Patent G
Patent H
PRI1
PRI2
PRI2
PRI3
PRI3
PRI4
PRI4
PRI5
PRI5
PRI5
PRI2
PRI3
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In a DOCDB family, patents are member of the same family if they share exactly the same priority 
documents. Figure 2 illustrates this for the eight patents in our example. Here, 
 patents C and D together form an DOCDB family, 
 patents G and H together form an DOCDB family, 
 all other patents each form their own DOCDB family, with just a single member. 
Members of a DOCDB family are very, very similar, which makes this family useful for a number of 
purposes. However, in the context of ETSI and the objective of ETSI to ensure FRAND commitments for all 
potentially essential patents, this family has disadvantages. Suppose Priority 2 (PRI2) in our example is the 
element that gives rise to potential essentiality. If a party would disclose Patent C, then the family would 
not encompass Patent B, even though it would include the potential essential element too. Furthermore, 
note that DOCDB families are, by their definition, always mutually exclusive, meaning that a patent can 
never be member of more than one family.  
Figure 2. The six DOCDB families in the set of patents shown in Figure 1. Patents C and D form one family,  
patents G and H one families, and all other patents are a one-member family.  
 
Priorities related to two DOCDB families are highlighted: the family with patent C and D (red) and the  
family with patent G and H (dark blue). All other patents, not highlighted, are each families by themselves. 
 
In an INPADOC family, patents are member of the same family if they share at least one priority with at 
least one other family member. Figure 3 illustrates this for the eight patents in our example. Here, 
 Patents A, B, C, D, E, F, G and H together form an INPADOC family. 
`
Members in a patent f mily s are x ctly the same 
priority
PRI1
PRI1
PRI2
PRI2
PRI3
PRI3
PRI2 PRI3
DOCDB family
PRI4
PRI4
PRI5
PRI5
PRI1
PRI1
PRI2
PRI2
PRI3
PRI3
PRI2 PRI3
INPADOC family
PRI4
PRI4
PRI5
PRI5
PRI1
PRI1
PRI2
PRI2
PRI3
PRI3
PRI2 PRI3
ETSI  IPR policy family 
PRI4
PRI4
PRI5
PRI5
Pate  3 and 4 are a family
Patents 7 and 8 are a family 
Patents 1, 2, 3, 4, 5, 6, 7 and 8 are a family
“PATENT FAMILY” shall mean all the documents having at least one priority in 
common, including the priority document(s) themselves. (ETSI RoP, Annex 6, §15) 
From the perspective of Patent 1, Patent 2 is a family member
From the perspective of Patent 2, Patents 1, 3 and 4 are family members
From the perspective of Patent 3, Patents 2, 4 and 5 are family members
From the perspective of Patent 4, Patents 2, 3 and 5 are family members
From the perspective of Patent 5, Patents 3, 4 and 6 are family members
From the perspective of Patent 6, Patents 5, 7 and 8 are family members
From the perspective of Patent 7, Patents 6 and 8 are family members
From the perspective of Patent 8, Patents 6 and 7 are a family member
Note that: 
• These are ego-families (only valid from the perspective of a ‘base’ patent) 
• Families are non-exclusive
Members in a patent family share at least one priority with 
another family member
PRI5 PRI5
PRI5
Patent A
Patent B
Patent C
Patent E
Patent F
Patent G
Patent H
Patent A
Patent B
Patent C
Patent E
Patent F
Patent G
Patent H
Patent D Patent D
Patent A
Patent B
Patent C
Patent E
Patent F
Patent G
Patent H
Patent D
 
9 
Figure 3. The one single INPADOC family in the set of patents shown in Figure 1. 
 
Members of an INPADOC family may be rather different from each other and may actually not directly 
share any priority (like patents A and H in our example, as well as many other example). For that reason, in 
the context of ETSI and the objective of ETSI to ensure FRAND commitments for all potentially essential 
patents, this family has some disadvantages too. Suppose Priority 2 (PRI2) in our example is the element 
that gives rise to potential essentiality. In that case, patents B, C and D are potentially essential. Patents A, 
E, F, G and H would not, but would still be part of the family for which a commitment is entered into. Note 
furthermore that in the INPADOC definition, families are mutually exclusive, meaning that a patent can 
never be a member of more than one family (just like in DOCDB families). 
As discussed above, neither the DOCDB or the INPADOC family definition are very suitable for the 
disclosure and FRAND licensing commitment process at ETSI. This is probably the reason why ETSI 
provides its own definition of a patent family, which reads as follows: “all the documents having at least 
one priority in common, including the priority document(s) themselves”.15 Using the same example as 
above, Figure 4 shows how the patent families following the ETSI family definition would look like. Let’s 
focus on patent C and assume that it is a patent disclosed to ETSI. Following the same language as ETSI, 
we will call the disclosed patent the basis patent.16 
Here, basis patent C is referenced by patent D and E as a priority document. In addition, patent C itself 
references patent B as a priority document. So, following the ETSI definition, from the perspective of 
Patent C, Patents B, D and E are family members. 
                                                        
15  ““PATENT FAMILY” shall mean all the documents having at least one priority in common, including the priority document(s) 
themselves. For the avoidance of doubt, “documents” refers to patents, utility models, and applications therefor.” Clause 15 of 
the ETSI Intellectual Property Rights Policy, in Annex 6 of ETSI (2018a). 
16  ETSI (2011). 
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Figure 4. Illustration of the ETSI family definition of the disclosed (‘basis’) patent C.  
 
Only the priorities related to family of disclosed (‘basis’) patent C are highlighted. Red indicates the priorities of  
patent C itself, pink indicates the priorities patent C directly shares with other patents. 
 
Family member relationships for the other patents are as follows: 
 From the perspective of Patent A, Patent B is a family member, 
 From the perspective of Patent B, Patents A, C and D are family members, 
 From the perspective of Patent D, Patents B, C and E are family members, 
 From the perspective of Patent E, Patents C, D and F are family members, 
 From the perspective of Patent F, Patents E, G and H are family members, 
 From the perspective of Patent G, Patents F and H are family members, 
 From the perspective of Patent H, Patents F and G are a family member. 
This full set of relationships is shown in Figure 5.  
Figure 5. The seven families following the ETSI family definition in the set of patents shown in Figure 1. Note that 
these are ego-families (as seem from one specific patent). 
 
From the perspective of the ETSI disclosure obligation, the ETSI patent family definition has clear 
advantages over DOCDB and INPADOC family definitions. The ETSI family definition ensures that all 
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patents that may also include the claims that give rise to essentiality are indeed part of the family, but 
that patents that do not include the claims that give rise to essentiality (because they do not share any 
direct priority with the disclosed patent) are not part of the family.17  
Note that patent families (following the ETSI family definition), by their mere definition, also have two 
characteristics that are notably different from DOCDB, INPADOC, and many other patent family definitions:  
 they are ego-families: they are only valid from the perspective of the disclosed (‘basis’) patent;  
 they are non-exclusive. 
This means that one should exercise caution with using these families in a cumulative way in order to 
determine the scope of the disclosed patent portfolio for a given company, for instance. Since patent 
families following the ETSI family definition can overlap, there may be (and there will likely be) duplication 
between those families.  Also, while it is certainly possible to do a citation analysis for an ETSI family as a 
whole, one should exhibit caution with ‘adding up’ the results of the different families of a given company, 
as there will be citation duplication between these observations.18  
Therefore, in this study, we will use the ETSI family definition where appropriate (e.g., in terms of 
disclosure of potential SEPs but use other family definitions where necessary.  
 
Summarizing: the set of patents shown in Figure 1 encompasses six DOCDB families, one INPADOC  
family, and seven families following the ETSI family definition (the latter being ego families, and very 
different in composition from the six DOCDB families).  
2.3 Retrieving and preparing data from the ETSI disclosure database 
The ETSI disclosure database is publicly available in two different forms:  
1. The ETSI Special Report SR 000 314, which is snapshot of the full ETSI database that is made 
available twice a year. By the time of writing this document, the most recent version was version 
V2.26.2, issued in November 2019.19 
2. The ETSI on-line disclosure database, available at ipr.etsi.org. This form delivers the most up-to-
date data. It has two different parts to it:  
a)  ‘declaration search’, where specific disclosures can be found, including the original 
disclosure itself (usually in facsimile format) as well as information on all the basis 
patents provided by the company in that disclosure and the ETSI family members of 
those patents (as automatically determined by the ETSI secretariat in collaboration with 
the EPO). The full history of a disclosure is made available as well. Note that disclosures 
often exist of numerous (numbered) disclosures, and that disclosures can exist of 
multiple basis patents and many family members.  
b) ‘Dynamic Reporting’, which allows users to create a dataset of selected patents, or the 
entire disclosure database, on the basis of a number of search criteria.  
 
For this study, we used the ‘Dynamic Reporting’ tool, as it allows to create a data set for the full disclosure 
database and is richest in terms of available data.20 We used this data as it was available as of 31 
February 2018.21  
                                                        
17  Note that also the ETSI family definition is not perfect in the context of disclosure. Should, in our example of disclosed basis 
patent 3, only PRI2 give rise to essentiality, but not PRI3, then patent 5 would be within the patent family definition but not be 
essential itself. Having that said, an alternative definition that would not have this disadvantage would need to rely on priority 
information on the individual claim level, and such information is not available in the patent system. As a consequence, a third 
party, such as a prospective licensee, would have a lot of trouble finding out for which patent the FRAND commitment is exactly 
entered into. Given this consideration, the ETSI definition is probably the best possible compromise here, and still considerably 
more appropriate than the DOCDB or INPADOC definition 
18  On strategy to deal with such citations is to count ‘distinct citing patent families’ instead of counting all citing patents (or patent 
families).  
19  This Special Report is publicly available at [www.etsi.org] using search term, “SR 000 314” 
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Our full retrieved data set from the Dynamic Reporting tool included 706,594 records of each eleven 
fields.22 In Table 2, an example of such a record is given. In this tool, a record is a unique combination of 
data in its eleven fields, but there may be significant duplication between records (e.g., another record may 
have exactly the same information in all or some patent fields but different information in the ‘ETSI 
Projects’ or ‘Standards’ field.). 
Table 2. Example of record in ETSI 'Dynamic Reporting' output 
Field name Value 
ETSI Projects 3GPP NR Rel 15 
Standards None 
Companies Sharp Corporation 
Patent Families |JP20110169318|WO2012JP69672| 
Application Number US201214236541 
Publication Numbers US2014177584 A1|US9801143 B2 
Title TERMINAL, COMMUNICATION SYSTEM, AND COMMUNICATION METHOD 
Patent Offices US  (UNITED STATES) 
Declarations ISLD-201802-006 
IPR Disclosures Disclosure number  194 
Declaration Date 20/02/2018 
 
There are three main23 fields that provide information on the disclosed patent in question:  
1. The ‘Application Number’ field provides information on the number assigned to the patent 
office to the application of the disclosed patent. If the patent is ‘harmonized’ by ETSI (see below), 
it is provided in a format known as EPODOC24. If not, the field contains the input as provided by 
the discloser. In that case, the format of the number is not harmonized, and in many cases, the 
number is incomplete or even erroneous (e.g., not an application number, but a publication 
number instead). 
2. The ‘Publications Number’ field provides one or two document identifiers of publications by a 
patent office related to that patent. These publications may be publications of a patent 
application (usually bearing the ‘kind codes’ A1, A2 or A3 as last characters of the number), 
publications of a granted patent (usually bearing the ‘kind codes’ B1 or B2 as last characters of 
                                                                                                                                                                        
20  For instance, the data from the Dynamic Reporting tool includes patent family information (given as application numbers of the 
priority documents) as well as up to two publication numbers of the disclosed patents.  
21  The dataset we use was created on 31 February 2018, at the premises of ETSI in Sofia Antipolis, France, with the kind help of 
the ETSI legal/ICT staff, to ensure the correct retrieval and interpretation of data. 
22  In the Dynamic Reporting tool, we selected the following fields: “ETSI Projects”, “Standards”, “Declaring companies”, “Patent 
family” and “Patent”. We only selected patents for which the disclosing company stated it to be ‘essential’. (Note that these 
selection fields are precisely the same as the fields that appear in the output of the tool.) Following advice of the ETSI staff, we 
did not select “Patent Office” or “Patent holder”, as these are known to be problematic if the full database is retrieved. For 
‘Patent holder’, for instance, the system would need to retrieve ‘life’ data from the EPO on recent ownership, and for many 
thousands of patents, that could take very long. As export options, again following advice of the ETSI staff, we selected “Export 
of detailed patent information”, “Declaration reference”, “Declaration date”, and “IPR disclosure”, and “Export of basis patent 
only”, and did not select “Export of detailed patent information”. Making other choices for downloading the full dataset (e.g . 
exporting all patents instead of only the base patent) could result in excessive file sizes (>10GB) which the ETSI server will not 
be able to generate.  
23  A fourth and fifth field are the “Title” and the “Patent Offices” fields. The title field (taken by itself) is not useful for 
identification purposes as it may not be unique (there may be other patents with the same title). For harmonized records, the 
“patent offices’ field does not provide any information that is not already in the other fields. For unharmonized records it may 
be informative (e.g. in cases where the discloser did not provide country information in other fields), but we do not consider 
these records, as explained below.  
24  EPODOC is a unique number to identify patent applications and is created by the EPO based on the DOCDB application number, 
application authority and application kind. See EPO, Data Catalog PATSTAT Global, Version 5.12 (for PATSTAT 2018 Autumn 
Edition), dated 01 October 2018.  
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the number), or other publications. If the patent is ‘harmonized’ by ETSI (see below), it is provided 
in a harmonized format of <country code> <publication number> <kind code>. Note that the 
numbering convention are different per patent office. For instance, the EPO uses the same 
number for the publication of a patent application and the associated publication of the patent 
grant (e.g. EP2741550A1 and EP2741550B1), while the US does not (example: 
US2014177584A1 and US9801143B2). If the patent is not harmonized by ETSI, the field 
contains the input as provided by the discloser. In that case, the formatting of the number is not 
harmonized, and in many cases, the number is incomplete or even erroneous (e.g., not a 
publication number, but an application number instead). 
3. The “Patent Families” field provides, for disclosures harmonized by ETSI, application numbers 
of patents that represent priority documents for the disclosure in question. (Note: this field does 
not include all family members!). In our retrieved data set, there were up to 27 numbers provided 
in this field. Sometimes the application number of the disclosed patent itself is also present in 
this field, sometimes it is not.25 Numbers in this field are provided in a format known as EPODOC.  
 
These three fields (and the up to 30 values in them) provide three broad routes towards identifying the 
identity of a patent disclosed to ETSI. It is important to note, however, that patents may be disclosed to 
ETSI for different ‘ETSI Projects’, and/or for different “Standards”, and/or in different ‘Declarations’. This is 
illustrated in Table 3, which shows all entries in the retrieved data set for which all three fields described 
above are exactly identical to the example already given in Table 2. Furthermore (but not shown in this 
example), there might also exist disclosures for the same patents from other declarants (called 
‘companies’ in the ETSI database), for instance by those that acquired a patent that was already 
previously disclosed at ETSI.  
Table 3. Other records concerning the same patent as in Table 1. 
 
As our objective for the data gathering/processing phase is to create a list of all unique, disclosed patents 
to ETSI (see Chapter 1), we combine all records that have precisely the same identification information in 
three fields discussed above. After this first duplication removing step, we have 48,684 records, 
considerably less than the 706,594 records before this step. (Note that after this step, there still might be 
records that have some overlap in patent information, but not fully the same information in all three 
fields; we will deal with this in a second duplication step which takes place after we matched various fields 
with PATSTAT).  
When performing the above deduplicating step, we always kept the record with the oldest disclosure date, 
since we primarily interested in the disclosure and its characteristics, not the ‘current owner’ (determining 
the actual owner which would, to be reliable, require many more efforts than just taking the latest 
                                                        
25  For 137,082 (19.4%) of the 706,594 records in our retrieved dataset, there is no patent family information (“NONE”). In the 
cases where exactly one patent family member is mentioned, it is the same patent as the patent listed in the Application 
Number field in about half of the cases (48.5%), and a different patent in the other cases. 
ETSI Projects Standards Companies Patent Families Application Number Publication Numbers Patent Offices Declarations IPR Disclosures Declaration Date
3GPP NR Rel 15 None Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201802-006 Disclosure number  194 20/02/2018
3GPP NR Rel 15 None Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201802-006 Disclosure number  194 20/02/2018
3GPP NR Rel 15 TS 38.213 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201802-006 Disclosure number  194 20/02/2018
3GPP NR Rel 15 TS 38.213 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201802-006 Disclosure number  194 20/02/2018
3GPP NR Rel 15 TS 38.214 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201802-006 Disclosure number  194 20/02/2018
3GPP NR Rel 15 TS 38.214 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201802-006 Disclosure number  194 20/02/2018
3GPP NR Rel 15 TS 38.331 (15.0.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201802-006 Disclosure number  194 20/02/2018
3GPP NR Rel 15 TS 38.331 (15.0.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201802-006 Disclosure number  194 20/02/2018
3GPP-radio None Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio None Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio TS 136 213 v12.5.0 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio TS 136 213 v12.5.0 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio TS 136 331 v12.5.0 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio TS 136 331 v12.5.0 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio TS 36.213 (12.5.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio TS 36.213 (12.5.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio TS 36.331 (12.5.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-radio TS 36.331 (12.5.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 None Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 None Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 TS 136 213 v12.5.0 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 TS 136 213 v12.5.0 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 TS 136 331 v12.5.0 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 TS 136 331 v12.5.0 Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 TS 36.213 (12.5.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 TS 36.213 (12.5.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 TS 36.331 (12.5.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
3GPP-Release-12 TS 36.331 (12.5.0) Sharp Corporation |JP20110169318|WO2012JP69672| US201214236541 US2014177584 A1|US9801143 B2 US ISLD-201707-017 Disclosure number  40 12/05/2017
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declarant in the disclosure database). This means that in the resulting data set, ‘disclosure date’ changes 
to ‘earliest disclosure date’, and ‘company’ to ‘Earliest disclosing organization’.26  
While the above set of 48,684 records is the input to our patent identification process as described below, 
the eventual number of actually different, unique patents is somewhat lower. Table 4 illustrates why this 
is the case. In some cases, we see records in the database that refer to exactly the same patents in the 
Application Number and Publication Numbers fields, yet have different information in the Patent Families 
fields. The exact reason for this is not known to us, but it might be caused by ETSI constructing family 
composition for different records at different points in time (and at a later point in time, new family 
members might appear). Whatever the reason is, in the perspective of our study, such records must clearly 
be merged, and so we eventually have somewhat less than 48,684 records.  
Table 4. Records with the same patent but different family information 
Patent families Application number Publication numbers 
US20010033141 
US20010279970P 
US20010933914 
US20010933977 US2002141391 A1 
US6707801 B2 
US20010279970P 
US20010933914 
US20010933977 US2002141391 A1 
US6707801 B2 
US20010279970P 
US20010933971 
US20010933977 US2002141391 A1 
US6707801 B2 
US20010279970P 
US20010933972 
US20010933977 US2002141391 A1 
US6707801 B2 
US20010279970P 
US20010933977 
US20010933977 US2002141391 A1 
US6707801 B2 
US20010279970P 
US20010933977 
WO2002US09830 
US20010933977 US2002141391 A1 
US6707801 B2 
US20010279970P 
US20010934021 
US20010933977 US2002141391 A1 
US6707801 B2 
 
2.4 Identifying the patents in the ETSI disclosure database 
In order to be able to perform the range analyses presented in this study, we attempted to identify all 
patents in the ETSI database in the EPO's PATSTAT. With over 100 million patent records from 90 patent 
issuing authorities, covering the mid-19th century up to today, and with two updates every year, PATSTAT 
has become a point of reference in the field of patent intelligence and statistics. To be able to identify as 
many patents as possible from our retrieved ETSI database (of late February 2019), we used the latest 
available PATSTAT version, which was the 2018 Autumn Edition.27  
We used all three fields in the ETSI database, described in the previous section, which can identify the 
patent in question. In some cases, a patent could only be identified from one field, in other cases from two 
or all three. If patents could be identified from more than one field (or by multiple values in that field), we 
used that information for consistency checks, allowing us to see when our matching instruments in one or 
more fields was not working well (or not working well for some specific patent offices, numbering ranges, 
formatting types, etc.). 
In principle, the data in the three above fields should match if the record was harmonized by ETSI, and 
may be matched if they were not harmonized by ETSI by nevertheless contained values in the same 
                                                        
26  This step also meant we had to drop the information for the following fields, as they could have different values: ETSI Projects, 
Standards, Title, Patent Offices, Declarations and IPR Disclosures. However, when necessary, these can be later easily added to 
our data (taking into account their possible 1:n relationship).  
27  Detailed information is available in EPO (2018).  
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formatting as the ETSI harmonization would have generated.28 (See below on how we prevented that the 
latter resulted in erroneous outcomes.) 
Table 5. Matching statistics 
Matching status Records Percentage of  
all records 
Percentage of 
matched 
records 
Matched by Application Number, Publication Number(s) and Patent 
Family number(s)  
28,561 58.7% 78.4% 
Matched by Application Number and Publication Number(s) 4,400 9.0% 12.1% 
Matched by Publication Number(s) only 1,110 2.3% 3.0% 
Matched by Patent Family number(s) only (*) 912 1.9% 2.5% 
Matched by Application Number only 782 1.6% 2.1% 
Matched by Publication Number(s) and Patent Family number(s)  394 0.8% 1.1% 
Matched by Application Number and Patent Family number(s)  255 0.5% 0.7% 
Not matched 12,270 25.2% n/a 
Total 48,684 100.0% 100.0% 
Note: (*): see text 
 
Table 5 shows our matching statistics. In total, 36,414 records were matched, and 33,610 (92,3%) were 
matched in at least two independent ways (i.e. categories a, b, f and g in the table). For a total of 
12,270 records, no match was found at all; in Section 2.4.2 we will further discuss the sources and 
consequences of that. We used the following matching priority, we used: (1) the first matched Publication 
Number, (2) the matched Application Number, or (3) the first matched Patent Family Number (which is a 
priority document, as explained above).  
2.4.1 Checking for possible errors in our identification process 
We checked whether our identification process performed well in two different ways: consistency checking 
and erroneous records checking.  
In terms of consistency checking, we found that out of the 32,961 records for which we both were able to 
match Publication Numbers and Application Number (i.e. categories a and b in Table 5), there were 
12 cases (0,036%) where these numbers lead to different information. We looked these cases up 
manually and hand-picked the correct patent, using the declarant and patent title information. 
Furthermore, with patents we matched via the Patent Family Number, we followed a slightly different 
procedure: as the field ‘Patent Family Number’ contains information priority document, it does not 
necessarily have to bring us the exact disclosed patent. But it should, in any case, bring us to the same 
INPADOC family of the disclosed patents (after all, they share a priority document). Out of the 
19,210 records where we had both Patent Family Number matching as well as some other matching (i.e. 
categories a, f, and g in Table 5), we found 35 cases (0,18%) where the INPADOC families were not 
identical. Also here, we looked these cases up manually and hand-picked the correct patent, using the 
declarant and patent title information. 
In terms of erroneous records checking, we analysed the technology classes (IPC) of all the 36,414 records 
with matched results for classes we should not expect to be present in a database of patents disclosed as 
potentially essential for mobile telecommunications. To this end, we selected all patents for which the 
                                                        
28  We chose this approach not only because it maximized the potential matching rate, but also because the retrieved ETSI 
database does not a priori allow to establish (at full certainty) whether a given record is harmonized or not. 
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share of ‘G’ and ‘H’ sections (the highest level of hierarchy of the IPC classification) is less than 50%.29 We 
found 123 patents (0.34%) that met that criterion, and after inspecting their titles concluded that all of 
these were erroneous entries. We removed them from our dataset. We did, however, perform further 
investigation to understand why they occurred, which revealed that 60 of these 123 patents were by one 
specific Chinese declarant, all disclosed on the same date and all referring to Chinese application numbers 
from one single year. The other erroneous records showed no distinguishable pattern (different companies, 
different match fields, different years) and can, we believe, only be attributed to erroneous inputs at the 
side of the declarants, or non-systematic identification problems in PATSTAT (but as such low occurrence 
that they are not a reason for concern). 
On the basis of the very low number of inconsistent or erroneous cases, we conclude that all our three 
matching strategies in PATSTAT were performing properly and consider our data to be reliable for the set 
of matched patents.  
2.4.2 Source and consequences of unidentified matches  
As can be seen in Table 5, no matches could be found for 12,270 records (52,2% of all probed records). 
We now discuss the possible sources and consequences of those nun-matches.  
In Table 6, we show examples of non-matched records, selected to illustrate different causes. (We only 
show the fields relevant to possible identification). Firstly, we see examples that are tough to identify 
because they are incomplete or do not use any harmonized formatting in the Application Number or 
Publication Numbers fields. With very considerable manual effort, some patents might still be identified 
(Examples 1 thru 3), but there are also records (Examples 4 thru 10) that are so incomplete that such a 
task would be virtually impossible.  
                                                        
29  We do so because it may be the case that a patent relevant for mobile telecommunications is also found by a patent examiner 
to be relevant for another category, outsize the G and H sections. A patent that is not present in the G or H section at all, 
however, is very likely not relevant for mobile telecommunications. 
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Table 6. Selected examples of non-matched records 
Example Patent 
Families 
Application 
Number 
Publicatio
n 
Numbers 
Title Patent Offices 
1 None 942 None Encryption system for digital cellular 
communications 
VE (Venezuela) 
2 None 1031 None Pop-subscription based mobile station idle 
mode cell selection 
AR (Argentina) 
3 None 1380 None Communication control technique for a 
radiotelephone system 
VE (Venezuela) 
4 None PCT/NL/95/00055 - 
94200236.1 
666 550 Data exchange system comprising portable 
data processing units 
EP (European 
Patent Office) 
5 None 006151-4 None Device and method for generating sync 
word and transmitting and receiving the 
sync word in W-CDMA co 
None 
6 None 00426/DENP/2004 None Radio resource control-service data unit 
reception 
None 
7 None 0006167-0 None device and method for implementing 
handoff in mobile communication system 
with short sync channel 
None 
8 None P-003071 335 Frequency synthesizer for broadcast 
telephone system having multiple 
assignable frequency channels 
None 
9 None 3045/86 67260 Subscriber unit for wireless digital 
telephone system 
None 
10 None 77/90 132016 A wireless digital communication system None 
11 None 20-2002-0012097 283799 Physical layer processing for wireless 
communication system using code division 
multiple access 
None 
12 None 15/324391 None Frequency hopping pattern with reindexing 
RB for D2D scenario 
US (United 
States) 
13 None 61/523,113 None Method and apparatus for handling 
additional power backoff 
US (United 
States) 
 
Examples 12 and 13 are interesting, as they refer to serial application numbers of patent applications. 
Example 12 has a formatting as used at the USPTO. The formatting is different from EPODOC formatting 
used for harmonized ETSI records and used in PATSTAT. With considerable effort, the patent (application) 
in question be found in PATSTAT, but this depends on whether it was abandoned by the owner or not, and 
on whether the application was done prior to March 2012 or not,30 among other things. Example 12 is a 
provisional patent application in the USPTO. Such an application will not directly lead to a granted patents, 
yet may or may not later be referred to as a priority document for a later application. Such provisional 
patent applications, especially if they never served as priority document later in their life, can be very hard 
to find in PATSTAT.  
Patents similar to examples 12 and 13 can be found in great number in the retrieved ETSI database. A 
non-exhaustive, quick look showed at least 3600 serial numbers of applications (more than 1200) or 
provisional applications (more than 2400) at the USPTO alone.  
We expect that for many of these patents, the patent owner later on, when a publication number was 
available, submitted a complete disclosure, resulted in a harmonized record. Yet, the ‘old’ unrecognized 
                                                        
30  Only from March 2012 on, the USPTO started to publish patent applications. Patent applications that fall before that publishing 
regime, and who did not see later grants, do have USPTO serial numbers (nn/nnn,nnn) but are not present in PATSTAT. 
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application was never retrieved. We manually looked at a dozen of cases where we managed to identify 
the patent, and found for each of them that this expectation was indeed the case 
All in all, our conclusion is that: 
- One part of the unmatched records concerns patents for which the owner provided incomplete or 
erroneous information.31 Such patents cannot be matched by us in an automatic fashion and 
doing so manually by us requires an effort that clearly falls outside the scope of this project. 
- Another part of the unmatched records concerns patents that are in the early application phase, 
including provisional patent applications. They may not have developed into real applications or 
granted patents at all. Or they may have developed into a real application or a real granted 
patent, but that patent might already be in the ETSI database, while the discloser did not remove 
the old, unharmonized record.  
All in all, we feel that there should not be a too great concern over these unmatched patents in the context 
of our study, where precision (are all the patents we identified actually disclosed patents) presides over 
recall (have we missed any disclosed parents).32  
2.5 Summary of dataset of identified basis patents 
The content of our final dataset of disclosed ETSI patents, in terms of the various types of patent families, 
is shown in Table 7. In ETSI’s disclosure process, the disclosure of one single patent suffices to disclose all 
existing and future members of its patent family (as per the ETSI family definition).33 Yet, declarants may 
sometimes disclose multiple members of a patent family.34  
After having matched with PATSTAT, we can also distinguish cases where two or more basis patents have 
exactly the same set of priorities35 (in the previous illustrative pictures, these could be patent 3 and 4, or 
patents 7 and 8). Removing these duplicates brought our dataset down from 34,711 records to 25,072, 
which is our final dataset.  
 
As can be seen in Table 7, our final set also covers 25,072 DOCDB families. That is logical; since the 
DOCDB family definition is smaller than the ETSI patent family and by definition covers all items of the 
latter, we should find exactly one unique DOCDB family for each identified unique ETSI basis patent. Yet, 
even though the number of DOCDB and ETSI families is the same, their content is very different (see 
Section 2.2), and DOCDB families would have been much less appropriate for the FRAND licensing 
commitment ETSI seeks to obtain.  
As we can also see in Table 7, there are fewer INPADOC families in the final set. This is also logical, since 
the INPADOC family is more inclusive, a single INPADOC family can encompass multiple ETSI family 
members. These INPADOC families are, again, of very different content than the ETSI families. 
                                                        
31  Note that, in recent years, ETSI has encouraged declarants to provide additional information for such patents to be able to 
match them. Processing this input by ETSI is a time-consuming proves, but step by step, the share of unmatched records is 
decreasing. 
32  Of course, in another context this could be different (e.g. a situation where a patent holder asserts a patent and the question is 
on the table whether that patent was disclosed at ETSI or not). 
33  “The obligations pursuant to Clause 4.1 above are deemed to be fulfilled in respect of all existing and future members of a 
PATENT FAMILY if ETSI has been informed of a member of this PATENT FAMILY in a timely fashion. Information on other 
members of this PATENT FAMILY, if any, may be voluntarily provided.”. Clause 4.3 of the ETSI Intellectual Property Rights Policy, 
in Annex 6 of ETSI (2018a). 
34  “Other patents of the patent family may have been explicitly disclosed on the declaration by the declaring company.” ETSI 
(2011), Section 5.3.3.  
35  This is the case of they belong to the same DOCDB family. 
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Table 7. Characteristics of final dataset of ETSI disclosed patents 
Type Unique occurrences  
in final dataset 
Note 
ETSI disclosed (‘basis’) patents, 
each with their unique ETSI patent 
family 
25,072 This are ego-families, valid from the perspective of the 
disclosed (‘basis’) patent. Families may overlap in terms of 
family members they cover. 
DOCDB patent families 25,072 These are mutually exclusive families (so can never overlap) 
INPADOC families 23,643 These are mutually exclusive families (so can never overlap) 
 
2.6 Creating patent families for our analyses 
As discussed above, our analysis will use the ETSI patent family definition where appropriate. We created 
such families by running SQL queries in the PATSTAT database, using the ETSI basis patents (disclosed 
patents) as the starting point. We implemented that in the following way: 
Patent A belongs to the patent family of the focal patent when at least one of the following conditions is 
satisfied:36 
1. Patent A is listed as a priority by that focal patent, 
2. The focal patent is listed as a priority by patent A, 
3. Patent A and the focal patent share one or more priorities. 
In order to double-check our mechanism, we manually inspected a number of patent families this way, 
and found that our algorithm creates the same patent families as those that are shown when the specific 
disclosure (ISDL) and disclosure number manually are looked in the ‘declaration search’ took of the ETSI 
IPR online database.37  
In Figure 6, a number of patents and their priority relations are shown. The square patent is the ETSI base 
patent, and the triangle patents are ETSI definition family members of that ETSI base patents, where the 
numbers refer to the above condition that makes them family member. The diamond patents have a direct 
or indirect priority relation to ETSI definition family members of that ETSI basis patents but are not ETSI 
definition family members of that ETSI basis patents itself.  
 
 
 
                                                        
36  When carrying out or work, we came across some cases in which a patent was in the same DOCDB family as the focal patent, 
yet none of the three conditions was met. We believe this may be the case of some missing or inconsistent priority data in 
PATSTAT. To ensure capture the full ETSI family, we add all patents that are in the same DOCDB family of the focal patent as 
well.  
37  We do note that in the ETSI retrieved database itself there are sometimes different lists of priorities listed for records for the 
same patent (see Table 4). We also note that PATSTAT is constantly updated, and in a newer version, some additional patents 
may show up in the family construction (newer patents that list one of the priorities we search for). In that sense, our results 
will not necessarily be identical to the families shown via the ETSI IPR ‘declaration search’ tool (which we believe is created 
once, and not recreated every time users consults the database).  
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Figure 6. Example of an ETSI patent family  
 
Note: Numbers shown on the basis of which of the three conditions they became family member (see above) 
 
The same patents are also shown in Figure 7, but now also showing which patents are in the same 
INPADOC family and in the same INPADOC family. 
 
Figure 7. ETSI patent family compared with DOCDB and INPADOC patent family 
 
1
2
3
3
ETSI family
ETSI basis patent (= disclosed patent)
ETSI-definition family member of the 
ETSI basis patent
No ETSI-definition family member of the 
ETSI basis patent
INPADC family
ETSI family
DOCDB family
ETSI basis patent (= disclosed patent)
ETSI-definition family member of the 
ETSI basis patent
No ETSI-definition family member of the 
ETSI basis patent
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2.7 Distinguishing standards in the ETSI disclosure database  
There is a very understandable desire to distinguish patents disclosed at ETSI for what one may call 
different standards (e.g., 2G, 3G, 4G and 5G). And many reports are making such a distinction, or at least 
claim to do so.  
Yet, this is a task that is not easily accomplished, for several reasons: 
1. The ‘ETSI project’ field in the ETSI disclosure process (and hence also in the database) is of free 
format, and a discloser can enter its own, new descriptions and acronyms. In our retrieved ETSI 
dataset, there are 333 different ETSI Project entries, with no apparent structure.38  
2. The selective ETSI Projects that do cover the bulk of the ETSI disclosures are very broad. They 
refer to activities in 3GPP, and such activities may cover 2G, 3G, 4G and 5G at the same time.  
3. ETSI disclosures may contain information in the field called ‘standards’ (which is also known as 
the ‘illustrative part of the standard’ in ETSI parlance. But this field is not mandatory for a 
discloser to fill in, and as of now, less than 25% of all disclosures in the ETSI database provide 
this information. And if they do so, it is not easy to translate that into technology generations 
either. The information in the field is unharmonized, and usually refers to 3GPP documents 
(Technical Specifications) than cannot 1:1 be linked to 3G, 4G and 5G either.39 
4. Generally, ETSI disclosures specify a specific Technical Specifications (TS) document of 3GPP for 
which the patent is potentially essential. A TS may (and most often does) relate to multiple 
generations (2G, 3G, 4G or 5G). Recently, the ETSI secretariat produced a spreadsheet that links 
specific TS documents, including their version number, to these four generations (ETSI, 2019). This 
spreadsheet shows, for instance, that TS24.011 V7.1.0 relates to 3G and 4G, whereas TS24.011 
V8.0.0 relates to 3G, 4G but also 5G. Most ETSI declarations include a TS number, and some (but 
certainly not all) also include a version number. Suppose we have a disclosed patent that includes 
both: TS24.011 V8.0.0. In that case, we can assume the patent is not believed to be potentially 
essential to 2G, but still we cannot infer anything whether it is believed to be potentially essential 
to 3G, to 4G, to 5G, or any combination of these.  
5. What is referred to as 2G, 3G, 4G and 5G relates especially to radio interfaces, but the ETSI/3GPP 
standards contain much more than radio technologies, such as technologies in routing (for which 
there are also several generations, but not 1:1 linked to radio technologies). They may relate to 
security, or the (U)SIM card. Patents may be believed to be technologies other than radio 
interfaces, for instance and then cannot be easily linked to 2G, 3G, 4G and 5G. 
6. Developments on different generations (e.g. 4G and 5G) to some degree take place in parallel. So, 
it is not possible to link to different generations merely on the basis of the moment of the 
invention (or patent application), or the moment of disclosure. 
All in all, we believe that, given the available information at the time we performed our analyses, it was 
impossible to break down ETSI disclosed patents for different generations (2G, 3G, 4G and 5G) in a reliable 
way.  
                                                        
38  When making selections in the Dynamic Reporting tool at ipr.etsi.org, a hierarchical tree is available for search purposes, but 
this tree contains much more entries that are “unharmonized’ than not, and the actual output in the retrieved data does not 
have that hierarchical structure.  
39  Furthermore, 3GPP, in its specification series, only distinguishes between three broad series: (a) 3G and beyond / GSM (R99 and 
later), (b) GSM only (Rel-4 and later) and (c) GSM only (before Rel-4). 
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3 A landscape analysis of ETSI disclosed patents  
Section 2 carefully described the procedure we followed to create a list of all the unique patents disclosed 
to ETSI and to identify all the members of the family of the disclosed patents. As discussed above, we 
then matched the disclosed (basis) patents to PATSTAT to gather additional and up-to-date data about 
these patents. In particular, we are interested in obtaining information about the timing of patent filing 
and disclosure, on the disclosing entities, information about the technological and geographical 
distribution, and proxies for the quality of the disclosed patents. This section describes the construction of 
the variables capturing this information and then presents descriptive statistics allowing us to have a first 
look at the disclosed SEP landscape.  
3.1 Construction of variables of interest using the PATSTAT database 
Several dates are important in the lifetime of a patent: the date of filling at the patent office, the date of 
publication of the application and search report, the date of grant, etc. The priority date is the date of the 
first filing of the application in any office, and in terms of dates available in patent databases, it is the 
date that comes the closest to the actual time of invention. Prior art can only be considered in the 
examination process if it is made public before the priority date.40 The date when the patent was disclosed 
at ETSI as potentially standard-essential is the date of disclosure. The disclosure lag is the difference 
between these two dates: how long after the priority date was the patent disclosed at ETSI. 
The number of applicants indicates a collaboration between organizations, while the number of inventors 
in a patent is related to the size of the research team. Both signal the size of the research project, which is 
related to the probability of developing “big innovations” (Mariani, 2004).  
The number of distinct IPC classes (at four digits) reported in the patent document captures the 
technological breadth of a patent, that Lerner (1994) shows is related to its value.  
The family size is the number of patents in the same family, while the number of legislations is the 
number of different patent offices of the applications in a family. This indicator captures the market scope 
of an invention (Lanjouw et al., 1998; Harhoff et al., 2003). As multiple applications are costly, applicants 
will be willing to bear these additional costs for protection only for valuable innovations. The family size 
and number of legislations can be calculated for any family definition (e.g., DOCDB, INPADOC, or the ETSI 
family definitions). 
To establish its prior-art, patent documents refer to previous patents and scientific literature. The number 
of references to earlier patents measures the degree of novelty of an invention and, therefore, it is 
associated with patent quality (Criscuolo and Verspagen, 2008). Self-citations are a particular class of 
backward citations as they are references to patents of the same applicant. These citations identify 
within-firm cumulative innovations, which might indicate particularly valuable lines of innovation. A patent 
application can have several publications (identified with distinct kind codes), so the number of backward 
citations is the number of unique citations to patent documents from any of those publications.  
The number of references to non-patent literature (NPL), that are mostly scientific literature, are generally 
used to measure the link between science and technological development (Narin et al., 1997). However, 
patents related to basic research are more valuable because covering more complex and fundamental 
knowledge (Cassiman et al.; 2008; Branstetter, 2005). The number of NPL references is the number of 
unique non-patent documents cited in any publication of a given application. 
Since the seminal work by Trajtenberg (1990), the number of citations (‘forward citations’) received by a 
patent has been extensively used as a measure of technical quality (Hall et al., 2005; Harhoff et al., 2003). 
The logic is quite simple and similar to the one of using citations to evaluate the quality of scientific 
publications. Important patents will foster follow-up innovations that will cite the originating patent. The 
number of forward citations is the number of unique patent publications that cite any publication 
associated with a given application. 
                                                        
40  The priority date can be found in PATSTAT under the “earliest filling date” column of tls201_appln table. 
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The next variable is the number of claims reported in the patent. Claims define the boundaries of the 
exclusive right and determine what can be legally protected and enforced. Claims have been used as a 
measure of patent value (Lanjouw and Schankerman, 2001, 2004) because they relate to the breadth of 
an invention and, therefore, the possibility of broader application. Furthermore, as in several patent 
systems fees increase with the number of claims, they are directly linked to costs that an applicant is 
incurring. When a patent application has several patent publications associated, we take the highest 
number of claims reported in a publication of this patent.  
Finally, patents are only enforceable if they are granted. The value of a patent that has been granted is 
higher than that of a patent application (Sherry and Teece, 2004). Our last variable is a dummy that 
indicates whether the patent has been granted.41 
3.2 A first look at the data 
As discussed in Chapter 2, we identified 25,072 disclosed patent families (following the ETSI family 
definition). In this section, we provide descriptive statistics on the basis patents associated with these 
families (i.e., the patent provided by the disclosing firm), using the bibliographic information as recovered 
through PATSTAT (2018b) of the patents that were actually disclosed in the disclosure letters to ETSI by 
the patent owners. If one of the patent families (following the ETSI family definition) we identified has 
more than one member disclosed at ETSI, we recover the patent-level information of the patent with the 
earliest disclosure date.42  
Table 8 reports general summary statistics about our main variables of interest. Following sections discuss 
a few of these dimensions in detail.  
3.3 Timing of disclosure, filing and age of the disclosed patent  
The first important dimension to analyse relates to the timing of disclosure of the SEPs to ETSI. As Table 8 
shows, about 76 percent of the patents disclosed to ETSI, were first disclosed after 2010, whereas less 
than 25 percent of the disclosed patents were disclosed before 2010. Figure 8 further explores the 
distribution of disclosed SEPs over time, showing the distribution over the year of the disclosure.43 It shows 
that the distribution is particularly skewed towards the end of the period taken into account, with more 
than nine thousand SEPs disclosed in 2017 and 2018 alone. 
The distribution of disclosed SEPs over time is somewhat less skewed if we consider the year of first 
priority of the patent (Table 8). In this case, the majority of the disclosed SEPs have a priority date that 
goes back to before the year 2010, whereas about 40 percent of the disclosed SEP families we consider 
was first filed from year 2010 onwards. Nevertheless, Figure 9, which displays the distribution in more 
details, shows that also in this case the distribution is quite skewed towards the second part of the time 
period considered, with more than 17 thousands disclosed patents and patent applications having a 
priority date from the year 2007 onwards, and almost 2,400 in the year 2016 alone.  
 
                                                        
41  This information comes directly from the column “granted” in table tls201_appln.  
42  Whenever we speak of ‘number of patents’ or ‘number of SEPs’ in this section, we mean the number of patents disclosed to 
ETSI, but we count only one patent for patent families (following the ETSI family definition) that have more than one patent 
disclosed. The patent-level information in the latter case, comes from the earliest disclosed patent.  
43  For this figure, 19 patents were not included as their records gave ‘January 1, 1900’ as a disclosure data and have to be 
considered as data errors. Given the size of our data set, discarding 19 patents does not significantly impact results.  
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Table 8. Summary statistics (data set: the 25,072 disclosed basis patents, coming from different jurisdictions) 
Variables Mean SD Median Min Max 
Nb. of inventors 3.12 1.8 3.0 1 19 
Nb. of applicants 2.07 1.9 1.0 1 20 
Age of the disclosed patent 5.26 3.9 4.0 0 34 
Nb. of IPC_4_DIGIT 2.23 1.6 2.0 1 30 
Nb. of legislations (DOCDB) 5.74 4.3 5.0 1 29 
Nb. of legislations (ETSI family definition) 5.72 4.6 5.0 1 29 
Nb. of legislations (INPADOC) 6.61 5.1 5.0 1 33 
DOCDB family size 8.14 10.6 6.0 1 269 
ETSI family size 10.4 20.3 7.0 1 640 
INPADOC family size 30.24 190.5 7.0 1 2938 (*) 
Nb. of claims 21.68 15.0 19.0 1 264 (*) 
Nb. of backward citations 10.30 22.8 4.0 0 1176 (*) 
Nb. of non-patent literature 3.67 9.7 1.0 0 128 
Nb. of forward citations 24.61 59.6 4.0 0 2478 (*) 
Granted 0.73  1.0 0 1 
Disclosure year Mean SD Median Min Max 
2000-2004 0.08  0 0 1 
2005-2009 0.15  0 0 1 
2010-2014 0.32  0 0 1 
Post-2015 0.44  0 0 1 
Priority year Mean SD Median Min Max 
Pre-2000 0.13  0 0 1 
2000-2004 0.14  0 0 1 
2005-2009 0.31  0 0 1 
2010-2014 0.27  0 0 1 
Post-2015 0.14  0 0 1 
N=25,072      
Note: (*) these are outliers in the data set, but not data errors; this table actually reports on the data as  
present in the PATSTAT database. In fact, some recent research papers investigate patents with  
extremely high numbers of backwards citations (Kuhn et al., forthcoming).  
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Figure 8. Number of patent families by year of first disclosure  
(data set: the 25,072 disclosed patent families).  
 
Figure 9. Number of disclosed patent families by earlies patent priority date  
within that family (data set: the 25,072 disclosed patent families). 
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Table 8 (on page 23) also showed the difference between the year of first priority and the year of the first 
disclosure, which we call the “Age of the disclosed patent”. The average is about 5.2.44 Also this distribution 
is skewed: the median age of the disclosed patent is four years, the longest age we encounter in the data 
is 34 years (note that this patent could not be enforced any more at the time it was disclosed). 90 percent 
of the disclosed SEPs has an age that is younger than 10 years. Figure 10 shows detail of the age 
distribution for disclosed patents (within the 90 percentile of age), where the age is the difference the two 
variables we just discussed: the year of first disclosure and the earliest priority year of the patents in the 
family. The figure also reports the distribution over different time windows of the year of first disclosure. 
The mode of the distribution is 2 years.  
Figure 10. Share of disclosed patents by age of the disclosed patent, in years  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions).  
 
  
                                                        
44  11 patents had negative disclosures lag which we believe is due to an error in the data and were not considered.  
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3.4 Technological trends 
As discussed in Section 3.3, the variable Nb of IPC_4_DIGIT reports the number of distinct IPC subclasses 
(i.e., four-digit level) assigned to disclosed SEPs. Table 8 (on page 23) already reported that, on average, 
disclosed SEPs are assigned to 2.2 different IPC subclasses. Figure 11 shows how almost 80 percent of 
the IPC four-digit classes assigned to disclosed SEPs belongs to only three subclasses: H04W, H04L, and 
H04B. Not surprisingly, these subclasses all belong to the H04 IPC class that covers Electric 
Communication Technique. 
Figure 11. Share of disclosed patents by main IPC subclasses  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions).  
 
Figure 12 illustrates the evolution of the distribution of the three most frequent subclasses plus a residual 
subclass, over the year of disclosure. As the figure shows, the concentration in the H04W subclass 
becomes especially evident with the patents disclosed after 2008.  
Figure 12. Density distribution of the main IPC subclasses by year of disclosure  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions). 
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Figure 13 shows that patents disclosed in more recent years are less diversified over IPC subclasses. 
Patents disclosed since 2010 represent almost 90 percent of the patents assigned to a single IPC 
subclass, but less than 60 percent of the patents assigned to more than four distinct IPC subclasses.  
More specifically the most frequent IPC subclass observed in the data is H04W, which covers Wireless 
Communication Networks, whereas H04B and H04L covers Transmission and Transmission of Digital 
Information respectively. Overall, less than 8 percent of the subclasses assigned to disclosed patents do 
not belong to the H04 class, with the most frequent classes outside H04 being G06 (Computing, 
calculating, Counting) and H03 (Basic Electronic Circuitry) 
Figure 13. Number of different IPC subclasses associated with our patents  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions). 
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3.5 Disclosing firms 
The ETSI IPR database contains the name of the “declaring company”,45 that is, the firm disclosing the IPR 
in question. This data reflects the ownership at the time the IPR was disclosed to ETSI.46 We analysed this 
data for the 25,072 patent families (following the ETSI family definition) in our dataset, where we looked 
up the earliest declaring firm for the family in question.47 As some companies used different names when 
declaring their patents, we performed name cleaning, but we did not consider mergers or acquisitions 
(M&A’s), transfer patent portfolios or parts thereof, ownership changes resulting from bankruptcy, and so 
on, as that goes beyond the scope of this study. Details on our name cleaning are provided in Appendix 1. 
Figure 14 shows our findings for the 25 largest companies. More detailed data, for all 67 companies that 
have disclosed 10 or more patents, is given in Appendix 2.  
It is important to keep in mind, however, that this data does not imply current ownership. Also, it does not 
tell whether and in what part of the world patents in this family are enforceable, and what the value of 
those patents is. Finally, as for all the data in this chapter, it does not tell us whether the patent family is 
factually essential.  
Figure 14. Number of disclosed patent families (following the ETSI family definition) by  
earliest disclosing company; shown for the 35 largest companies; full time period (1990-2019).  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions) 
  
                                                        
45  Even though ETSI uses the word ‘company’ (and we follow that convention in our report), note that this may be any type of 
entity (e.g., public research organisations, associations). For the term ‘declaring’, see also Section 1.2 
46  While technically the ETSI IPR policy does allow firms to inform ETSI of IPR held by third parties, this never seems to be the case 
for the records in the database. In the on-line ISDL declarations, we invariably see stated that the “The declarant and/or its 
affiliates are the proprietor of the IPR(s).” 
47  It seems there might be instances where after a disclosure was made by a ‘new’ owner of a patent, the record of the original 
patent owner was longer no present in the ‘dynamic reporting’ tool of the ETSI IPR database. We discussed this with ETSI staff 
and the exact cause of this is not known, neither the extent at which this may occur.  
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Disclaimer: patents in the disclosed families shown here: 
• may not be owned (anymore) by the disclosing firm,
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• may not be granted,
• may not be enforceable (valid, non-expired, renewal fees
paid, etc.),
• may greatly differ in technical merit
• may relate to functionalities not relevant for a certain
product category (e.g. a mobile phone or an
infrastructure product),
• may relate to optional features that might not be used in
a given device conforming to the standard.
Moreover, the patent families shown here may differ in terms 
of geographical coverage.  
Note that this data set includes all ETSI standards: those 
based on 3GPP Technical Specifications as well as others 
(DECT, TETRA, etc.)  
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We also looked at spatial patterns in patent family disclosure. In order to do so, we determined the ‘home 
country’48 for all 148 (cleaned) declaring company names in the database. As can be seen in Figure 15, the 
largest number of patent families (following the ETSI family definition) are disclosed by Chinese firms 
(27.3%), followed by US firms (21.5%), South Korean firms (19.3%) and by European firms (19.2%).  
Figure 15. Share of number of disclosed patent families (following the ETSI family definition) by home country/region  
of disclosing firm (data set: the 25,072 disclosed basis patents, coming from different jurisdictions) 
 
Notes: Europe includes companies from EU countries, Switzerland and Norway.  
The ‘other’ category includes firms from Israel, Turkey, and New Zealand. 
 
  
                                                        
48  We consider the ‘home country’ as the principle country of the firm, and typically it is where their factual headquarters are 
(which is not necessarily where the company is legally registered). In case of doubt, we consulted the ISDL declarations the 
company made to ETSI (including the underlying facsimile documents). For the vast majority of entries, the home country is 
relatively easy to establish. However, there are some exceptions, typically smaller companies. An example is Vimatix: on the 
facsimile underlying the ISDL statement submitted to ETSI, this company is called ‘Vimatix (Technologies) Ltd’, the provided C/O 
postal address is in the US, yet the fax is sent from Israel, and the stamp of the firm at the signature page reads “Virgin 
Islands’. 
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These spatial patterns also change over time (Table 9, same data visualized in Figure 16). Here we see 
that it was initially the European companies that were leading in the number of disclosed patent families 
(following the ETSI family definition).49 Other countries/regions in the world increasingly caught up, and 
Chinese companies took over the lead from 2010 on.  
Table 9. Number of disclosed patent families (following the ETSI family definition) by home country/region of 
disclosing firm, over time (data set: the 25,072 disclosed basis patents, coming from different jurisdictions) 
Country/ 
region 
1990– 
1994 
1995– 
1999 
2000– 
2004 
2005– 
2009 
2010– 
2014 
2015– 
2019 
Full period 
CN 0  (0%) 0  (0%) 0  (0%) 506  (17%) 2135  (27%) 4214  (34%) 6855  (27%) 
US 6  (55%) 48  (22%) 474  (32%) 767  (25%) 1835  (23%) 2194  (18%) 5324  (21%) 
KR 3  (27%) 4  (2%) 81  (6%) 520  (17%) 1495  (19%) 2747  (22%) 4850  (19%) 
Europe 2  (18%) 158  (71%) 778  (53%) 921  (30%) 1259  (16%) 1698  (14%) 4816  (19%) 
JP 0  (0%) 9  (4%) 78  (5%) 245  (8%) 891  (11%) 1347  (11%) 2570  (10%) 
TW 0  (0%) 0  (0%) 24  (2%) 13  (0%) 124  (2%) 163  (1%) 324  (1%) 
CA 0  (0%) 1  (0%) 16  (1%) 62  (2%) 164  (2%) 79  (1%) 322  (1%) 
Other 0  (0%) 2  (1%) 8  (1%) 0  (0%) 0  (0%) 1  (0%) 11  (0%) 
TOTAL 11 222 1,459 3,034 7,903 12,443 25,072 
Notes: Europe includes companies from EU countries, Switzerland and Norway.  
The ‘Other’ category includes firms from Israel, Turkey, and New Zealand. 
 
Figure 16. Share of disclosed patent families (following the ETSI family definition) by home country/region of 
disclosing firm, over time (data set: the 25,072 disclosed basis patents, coming from different jurisdictions).  
  
Note: the 1990-1996 time frame is omitted in thus picture, as there are few observations in that time slot. 
  
                                                        
49  Even though companies from the US were the largest disclosers of patents in the period from 1990 to 1994, there are only 
11 disclosed patent families in this period. 
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3.6 Patent authorities 
Another interesting dimension concerns the patent authorities of the basis patents which are disclosed to 
ETSI. Figure 17 reports on their distribution. Most of the disclosed basis patents (38%) were first filed at 
the USPTO (US). A substantial amount of applications disclosed as SEPs were directly filed as international 
(PCT) applications and then report WIPO (WO) as the filing authority. More than 4,500 of the disclosed 
patents were first filed at the Chinese patent authority (CN), and less than a 1,000 at the Korean and 
Japanese patent authorities. Figure 17 also allows us to gather some insights about how this distribution 
evolved over time. In particular, the figure clearly shows that disclosed basis patents filed at the Chinese 
patent authority come overwhelmingly from more recent years, with only a minority of disclosed SEPs 
filed in China before the year 2000. The distribution over time of international applications follows a 
similar trend. 
Figure 17. Distribution of disclosed patents by patent authority and time of disclosure  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions). 
 
 
Remarkably, only 2,151 basis patents (8.6 percent of the full sample) were first filed at the European 
Patent Office (EP) as can be seen in Table 10, Column 2. Nevertheless, 13,938 basis patents filed at 
authorities different from the EPO (54 percent of the total) were part of an ETSI family that included at 
least one EPO patent, whereas 46 percent of the disclosed basis patents were not related to any EPO 
patent. Table 10, Column 3, reports similar figures for the sample that exclusively consider granted 
disclosed basis patents. Table 10, Column 4, finally, shows the number of families that include a granted 
EPO family member.50 Figure 18 visualizes the data in Table 10. 
 
                                                        
50  Note that (i) ETSI families are non-exclusive, so the same EPO patent can belong to more than one family (so the final number 
to be investigated in an assessment system could be a bit lower), (ii) ETSI families may include more than one EPO patent (so it 
can also be somewhat higher). 
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Table 10. Number of disclosed patent families (following the ETSI family definition): total, with granted basis patent 
and with granted EPO patent.  
Patent families Total number With granted  
basis patent 
With granted  
EPO patent 
Total number of disclosed families (patent families 
following the ETSI family definition) 
25,072 (100%) 12,760 (100%) 8,320 (100%) 
 .. which have an EPO basis patent  2,151 (8.6%) 1,449 (11.4%) 1,449 (17.4%) 
 .. which do not have an EPO basis patent but 
include an EPO family member 
13,938 (55.6%) 8,369 (65.6%) 6,871 (82.6%) 
 .. which do not have an EPO basis patent and do 
not have an EPO family member 
8,983 (35.8%) 2,942 (23.1%) n/a 
 
Figure 18. Number of disclosed patent families (following the ETSI family definition):  
total, with granted basis patent and with granted EPO patent. 
 
 
Finally, we note that the above numbers are for the entire ETSI IPR database. The lion’s share of these 
patent families is about ETSI/3GPP cellular standards 2G (GSM), 3G (UMTS/W-CDMA), 4G (LTE) and 5G. The 
total number of families declared for other ETSI standards (such as TETRA, ERMES, and the various DVB 
standards), is very low: we counted appropriately 380 families51 out of our total of 25,072 families, and 
another 610 families for which the database field “standard” was equal to “none” and which may, or may 
not, relate to cellular standards. 
 
                                                        
51  Because the information in this field of the database is not harmonized and not always unambiguous, it is difficult to come to 
definitive numbers. 
which do not have an EPO basis patent 
and do not have an EPO family member 
which do not have an EPO basis patent 
but include an EPO family member 
Which have an EPO basis patent 
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3.7 Patent family size, claims, and backward and forward citations  
Figure 17, in the previous section, only reported on the authority where the patent disclosed in the ETSI 
disclosure was first filed. Clearly, the patent applicant then may have sought patent protection in other 
jurisdictions, by extending the application to other patent authorities. As discussed in Section 3.1, the 
number of jurisdictions in which an invention is protected is correlated with the economic value of the 
invention (Lanjouw et al., 1998; Harhoff et al., 2003), as filing patents in multiple jurisdictions is costly. 
Table 8 (on page 23) reported the average number of legislations in which the inventions disclosed in the 
disclosed patents are protected. As discussed above, we consider two types of families to count the 
number of jurisdictions: DOCDB and INPADOC. As the table shows, the average DOCDB family of the 
disclosed patents spans 5.7 jurisdictions, as does the ETSI family, whereas the average INPADOC family 
spans 6.6 jurisdictions. Figure 19 reports the distribution of disclosed SEPs by the number of legislations 
for all three kinds of patent families within the 98th percentile. The distributions are overall quite similar, 
although, as expected, the INPADOC-based count appears to have a longer tail. 
Figure 19. Distribution of disclosed patents by number of legislations, for the three different patent family  
definitions (data set: the 25,072 disclosed basis patents, coming from different jurisdictions). 
 
Table 8 (on page 23) also reports information about the average size of the DOCDB patent family, ETSI 
patent family and the INPADOC family of the disclosed patents. Given the substantial differences in the 
definition, we observe an important difference in the average of these two variables, with the average 
DOCDB family having 8.1 members, the average ETSI family having 10.4 members, and the INPADOC 
more than 30 members. 
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Another variable that has been used in the patent literature to partially capture the value of patent relates 
to the number of claims included in the patent. For measurement, we use the maximum number of claims 
associated with one of the patent publications documents. Table 8 (on page 23) already reported that, on 
average, patents disclosed as SEPs to ETSI have about 21 claims.52 However, the number of claims 
included in a given patent application is heavily affected by the institutional environment of the patent 
authority where the patent application was filed. To draw a more complete picture of the distribution of 
the number of claims, Figure 20 reports the detail of the distribution of disclosed patents for EPO and 
USPTO disclosed basis patents with at most 50 claims (95 percent of the disclosed patents). Interestingly, 
we observe a large concentration of disclosed patents that have exactly 20 claims for USPTO patents and 
exactly 15 claims for EPO patents. 
Figure 20. Distribution of disclosed SEPs by number of claims for EPO (left)  
and USPTO (right) disclosed basis patents. 
 
Note: the two panels are based on different subsets. In the set of EPO basis patents, disclosed patents  
filed by European firms may be prevailing, whereas in the set of USPTO, disclosed patents filed by U.S. firms  
may be prevailing. As a consequence, the two sets therefore may not be comparable. 
Figure 21 reports instead the share of disclosed patents as divided into seven categories based on their 
claims number, by the timing of disclosure. This figure suggests that the number of claims per disclosed 
patents is pretty stable over time both for EPO and USPTO disclosed basis patents.  
Figure 21. Share of disclosed basis patents by number of claims and time of  
disclosure for EPO (left panel) and USPTO (right)  
   
 
                                                        
52  Note: claims are only available for 9,608 patents in our sample, granted USPTO and EPO patents). 
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As discussed in Section 3.1, the variables Nb. of backward citations and Nb. of non-patent literature count 
the number of references to the prior art made by a patent. From Table 8 (on page 23) it is clear that both 
these variables have a skewed distribution: on average disclosed SEPs make about 10 references to earlier 
patents, whereas the median is four.  
Figure 22 and Figure 23 illustrate the distributions of backward citations and non-patent literature 
references for EPO and USPTO disclosed basis patents, respectively. Our data confirm the common 
understanding that the number of backward citations and references to the non-patent literature made by 
a patent depend to a significant degree on the institutional rules of the patent office where the application 
is filed. For instance, applicants filing a patent application at the USPTO have to comply with the so-called 
duty of candour. This rule requires applicants to disclose to the patent office all information known to 
them to be material to patentability. Such a requirement results in a larger number of backward citations 
and references to the non-patent literature, compared to applications filed at other patent offices, such as 
the EPO. Indeed, we see that the median number of backward citations for USPTO is 11, whereas that for 
the EPO is 3. For NPL citations, the median of USPTO patents is two and for the EPO is one. Nevertheless, 
among both EPO and USPTO disclosed basis patents there is a similar proportion of patents, about one 
third, that makes no reference at all to the non-patent literature. 
 
Figure 22. Distribution of disclosed patents by number of backward  
and NPL citations for EPO disclosed basis patents. 
 
 
We observe some extreme outliers in these variables. One of the disclosed SEP in our sample listed more 
than a thousand patents as relevant prior art. We see a similar pattern for the references to the non-
patent literature. On average, disclosed SEPs make 3.7 references to the non-patent literature, but the 
median value (only one reference) is considerably smaller than the mean. We also observe that very few 
disclosed SEPs (5) make more than a hundred references to the non-patent literature.  
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Figure 23. Distribution of disclosed patents by number of backward and  
NPL citations for USPTO disclosed basis patents. 
 
 
 
Also the distribution of the variable Nb. of forward citations is heavily skewed. Table 8 (on page 23) 
reported that on average disclosed SEPs receive about 24 citations from later patents. Nevertheless, the 
median in our sample is only four forward citations, with a few patents (5) collecting more than a 
thousand forward citations each. A considerable share of disclosed SEPs (37 percent) did not receive any 
forward citation so far. Almost 70 percent of the disclosed patents received less than ten forward 
citations, and 90 percent of the disclosed SEPs less than 50 forward citations. However as discussed 
above, these figures are heavily affected by the institutional framework of the receiving office. 
Figure 24 displays the distribution of disclosed patents by the number of forward citations received for the 
EPO and USPTO disclosed basis patents. As expected, USPTO disclosed basis patents receive substantially 
more citations than their EPO counterparts. The average number of forward citations received by a USPTO 
disclosed basis patent is 44, whereas EPO disclosed basis patent on average receives only 4 citations. 
Interestingly, a relatively large share of EPO disclosed patents (66 percent) received no forward citation so 
far, whereas only 8 percent of USPTO disclosed basis patents has not received any citation yet. 
 
38 
Figure 24. Distribution of disclosed EPO (above) and USPTO (below) basis patents by number of forward citations. 
 
3.8 Legal status 
Finally, Table 8 (on page 23) already reported information about the variable Granted, which reports 
whether the basis patents (or applications, see above) disclosed to ETSI were actually granted patent 
protection in the jurisdiction where they were filed.53 Note that when a patent is not granted, it may be 
rejected, but also may be waiting for a decision (pending), withdrawn or abandoned by its applicant. On 
average, the disclosed SEPs (basis patent) obtained patent protection in 73 percent of the cases. However, 
this statistic is clearly affected by the duration of the prosecution process, which, at several patent 
authorities, could take on average more than three years. If we considered only patents applied for before 
the year 2015, we would observe a much higher grant rate, close to 87 percent. Figure 25 illustrates well 
the importance of this effect of data truncation, with the overwhelming majority of disclosed SEPs being 
granted patent protection before 2015, and a falling share of granted patents towards the end of the 
period taken into account.  
Figure 26 reports the grant rate by the main patent authorities for disclosed SEPs filed before 2015. As 
the chart shows, all the main patent offices granted more than 70 percent of the disclosed SEP 
applications. However, some offices like the USPTO, the Korean and the Japanese patent office have a 
substantially higher grant rate than the European and the Chinese patent office.  
                                                        
53  As discussed above, we did not consider international applications (WO/PCT) here, as these applications cannot be granted as 
such.  
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Figure 25. Distribution of disclosed SEPs by legal status and application year  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions).  
 
Figure 26. Grant rate by main patent authorities for disclosed SEPs filed before 2015  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions).  
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4 Disclosed SEPs quality assessment  
As part of this project, we were asked by the European Commission to investigate the quality of disclosed 
SEPs. In this section we aim at assessing how the quality of disclosed SEPs compare to a group of suitable 
control patents (i.e., never disclosed to ETSI).  
The term ‘quality’ can mean very different things to different people; therefore, we first discuss what type 
of characteristics we look at in this chapter in Section 4.1. In Section 4.2 we discuss the sample of 
disclosed patents we will use for the analysis, in Section 4.3 the variables we use, and in 4.4 explain how 
we created the control set. Section 4.5 presents the analysis.  
4.1 Patent quality: technical merit and economic value 
As indicated, the term ‘quality’ can mean very different things to different people. One can, at least, think 
of the following ‘dimensions’ of quality: 
 technical merit: the technological contribution to the field; could be described as the “size of the 
technological inventive step” associated with the invention that eventually receives a grant, as 
compared to the prior art. 
 economic value: economic returns that a patent generates, in terms of direct revenue, or in 
terms of other benefits from having an exclusive right (e.g. market position for a product). The 
latter category is sometimes coined the ‘patent premium’.  
 legal quality: the likelihood that a patent survives if challenged in court.  
In this study we will focus on the first two categories. The challenge here is that none of the above 
dimensions can be directly measured. At best, one can look at observable characteristics of patents that 
are believed to be associated with these dimensions, which are often referred to as proxies (see 
Squicciarini et al., 2013, for an overview). The second challenge is that these dimensions are related to 
each other: a patent with a high technical merit is quite likely to be a patent with high economic value 
(although that does not always need to be true). Indeed, in the literature, technical merit and economic 
value are found to be positively correlated (de Rassenfosse and Jaffe, 2014). Relatedly, some observable 
characteristics are associated with both dimensions. A third challenge is that proxies are indirect and per 
definition imperfect. Studies have shown that, even when a number of proxies are combined in an 
optimum way, there is still a significant degree of unexplained variance in measuring a dimension like 
patent value (Gambardella et al., 2008).  
Table 11. Observable patent characteristics related to different quality dimensions 
Observable 
characteristic
s 
Can be measured as Considered as a proxy 
of technical merit 
Considered as a proxy 
of economic value 
Forwards 
citations 
Total number of citations 
received from any other 
patent publication (see §3.7). 
Yes Yes 
Number of 
legislations 
Number of legislations 
covered by the applications 
in the same ETSI patent 
family (see §3.7). 
 Yes 
Number of 
claims 
Maximum number of claims 
reported by the publication 
documents (see §3.7). 
Yes  
Years of 
renewal 
Number of years for which 
the patent is renewed (see 
§4.3). 
 Yes 
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The discussion in the economic literature on the pros and cons on the various proxies is complex and lively, 
and it is outside the scope of this study offer a voluminous treaty on this topic, and we will follow a 
pragmatic approach. We focus on a selection of widely established metrics. Table 11 introduces the 
observable characteristics we will focus on, and how they are related to technical merit and economic 
value. In addition, we will also look at an existing composite measurement as used by the OECD, 
associated with both dimensions. 
4.2 Mapping ETSI disclosed patents to EPO/USPTO databases 
The disclosed basis SEPs discussed in Chapter 2 and 3 come from many different legislations. Yet, for 
many of the observable patent characteristics we consider in this chapter, it is known that they differ 
considerably across legislations. For instance, a patent at the USPTO has a much higher likelihood of 
receiving citations than one at the EPO. Therefore, patents from a given office should be only compared to 
other patents from that same office. Because the analysis may to some degree also depend on specific 
(institutional) aspects of the patent office,54 we decided not to look at patents from one office only but 
look at patents from two offices: EPO and USPTO. For reasons of comparability, we furthermore limit our 
analysis to granted patents.  
Our set of EPO patents for this chapter consists of the granted, disclosed basis EPO patents, plus granted 
EPO patents that are family member of a disclosed base patent of another patent office.55 Likewise, our 
set of USPTO patents for this chapter consists of the granted, disclosed basis USPTO patents, plus granted 
USPTO patents that are family member of a disclosed base patent of another patent office.  
Our initial EPO set includes 4,758 granted patents, and our final USPTO set includes 13,230 granted 
patents. Both sets together cover 17,994 granted patents. (Later we will slightly reduce the number of 
patents in these sets when we are creating the control samples.)  
4.3 Observable characteristics related to patent quality  
For this study, we focus on a set of observable characteristics (variables) that are generally related to the 
quality of patents. These variables, together with their sources, are listed in Table 12. Variables calculated 
from PATSTAT are already described in detail in Sections 0 and 3.7. Below, we discuss the variables that 
were not already presented in that section.  
The variable RENEWALS is the number of years for which the patent is active starting from the filing 
year.56 Patents rights generally last up to 20 years; however, they need to be periodically renewed. As 
renewal is costly, and some offices use increasing fees, applicants will be willing to pay an increasing 
amount of money only for those patents that are valuable in their own perception (Lanjouw et al., 1998). 
Similar to the number of legislations and the number of claims, renewals are directly related to the private 
costs of protection that an applicant is willing to pay (Pakes and Schankerman; 1984). 
As there are numerous indicators linked to different aspects of patent quality, there were some attempts 
to construct a composite index. Lanjouw and Shankerman (2004) use a multiple-indicator model with one 
common latent factor. This latent factor is the unobserved characteristic of a patented innovation that 
simultaneously influences the number of forward citations, the number of backward citations, the number 
of claims, and the number of legislations. Following this approach, the variable QUALITY_INDEX results 
from a latent variable model, where the components are as follows: the number of forward citations (up 
to 5 years after publication), INPADOC patent family size,57 number of claims, and the patent generality 
                                                        
54  See for instance Figure 20, where one can see different peaks for the two patent offices, related to the different fee structure 
used by these offices.  
55  As the ETSI family might include more than one EPO patent, we choose the one with the earliest filing date. In the case of 
multiple patents filed on the same filing date, we randomly select one of them. 
56  Definition taken from Squicciarini et al. (2013), where the OECD data source is described we use for this variable.  
57  Note that OECD Quality Database calculates this composite quality index using the INPADOC family definition and not on the 
ETSI family definition used in other analysis presented in Section 4.  
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index58. Such variable then captures the technological importance of the invention and its market 
opportunities. 
Table 12. Description of the variables used in the value analysis and their source 
Variable Definition Data source 
NUM_FORW_CIT Total number of citations received from any other 
patent publication (see §3.7). 
Our calculations using the EPO-PATSTAT 
Database (Autumn, 2018) 
NUM_LEGISLATIONS Number of legislations covered by the applications 
in the same ETSI patent family (see §3.7). 
Our calculations using the EPO-PATSTAT 
Database (Autumn, 2018) 
NUM_CLAIMS Maximum number of claims reported by the 
publication documents (see §3.7). 
Our calculations using the EPO-PATSTAT 
Database (Autumn, 2018) 
RENEWALS Number of years for which the patent is renewed 
(see §4.3). 
OECD Quality Database (Version 2019)  
QUALITY_INDEX Composite index calculated using the number of 
forward citations (up to 5 years after publication), 
INPADOC family size, number of claims and the 
patent generality index (see §4.3). 
OECD Quality Database (Version 2019) 
NUM_BACK_CIT Number of citations to patents made by the patent 
(see §3.7). 
Our calculations using the EPO-PATSTAT 
Database (Autumn, 2018) 
NUM_NPL_CIT Number of citations to scientific articles made by 
the patent (see §3.7). 
Our calculations using the EPO-PATSTAT 
Database (Autumn, 2018) 
NUM_IPC_4_DIGIT Number of distinct IPC classes (4 digit) reported in 
the patent (see §0). 
Our calculations using the EPO-PATSTAT 
Database (Autumn, 2018) 
 
4.4 The construction of the control set 
Now we have identified the disclosed patents to be used in the analysis (Section 4.1), we need to identify 
suitable control patents. Following a standard approach in the literature (Rysman and Simcoe, 2008; 
Bekkers et al. 2016), the control is built by matching the patent office, the filing year, and the IPC main 
group.59 Furthermore, to control for potential differences in the application procedure, we also match 
patents on whether or not there is an earlier Patent Convention Treaty (PCT) application of the patent. The 
data source for the control set is the EPO-PATSTAT Database.  
Furthermore, to prevent that selected control patents are actually a family member of a disclosed ETSI 
patent, we ensure that none of the control patents is part of the INPADOC patent family of any ETSI 
disclosed patent.60 In Figure 27, we illustrate this graphically (for the same patents used in Figure 6 and 
Figure 7 of Section 2.6, above). 
Depending on whether a patent is granted at the USPTO or the EPO, the matching procedure differs. 
USPTO patents have a primary class that makes straightforward the choice on which IPC main group to 
perform the matching. On the contrary, EPO patents report IPC classes in alphabetical order, so we decided 
to assign each application to the most recurrent IPC main group. A similar approach is used for 1,509 
USPTO patents that do not have a primary IPC main group.  
 
                                                        
58  The generality index captures the range of technological field that are affected by an invention (Henderson et al., 1998). This 
indicator is based on the Hirschman-Herfindahl Index (HHI) of the dispersion of the distribution of the shares of forward 
citations over the IPC classes. 
59  PC classification symbols are made up of a letter denoting the IPC section (e.g. A), followed by a number (two digits) denoting 
the IPC class (e.g. A63), then a letter denoting the IPC subclass (e.g. A63B). A number (variable, 1-3 digits) denotes the IPC main 
group (e.g. A63B49). This is followed by a forward slash "/" and a number (variable, 1-3 digits) denoting the IPC subgroup (e.g. 
A63B49/02). 
60  While technically we could also have decided that the two patent families following the ETSI family definition should not 
overlap, this would require us to calculate ETSI-definition family members for all potential control group member patents. With 
our simpler, INPADOC non-overlapping approach, our goal is already reached as well. After all, if the control group patent is not 
in any INPADOC family of an ETSI patent, it can be definition never be member of an ETSI-defined family of an ETSI patent. 
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Figure 27. ETSI disclosed patents and control group patents 
 
 
From the pool of potential controls, containing over 5.8 million patents, we randomly sampled – without 
replacement – up to 5 control patents for each disclosed patent. For a (very) small fraction of the ETSI 
disclosed patents, no matching control patents could be identified. For this reason, we removed these 
disclosed patents from our analysis.  
Ultimately, our EPO set consists of 4,607 granted disclosed EPO patents and 19,477 matched control 
patents, and our USPTO set consists of 12,832 granted disclosed USPTO patents and 56,100 matched 
control patents.61 
  
                                                        
61  On average each EPO and USPTO disclosed patent has 4.22 and 4.37 control patents respectively. 
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4.5 Analysis if disclosed vs. control group patents 
First, we compare the sample means of the selected variables for the disclosed patents and the control 
group. The results are shown in Table 13 and Table 14.  
Table 13. Test for equality of the mean (disclosed vs. controls) for the EPO patents 
 Controls Disclosed   
Variable Obs. Mean Obs. Mean Diff t-stat 
NUM_FORW_CIT 19,477 1.812 4,607 2.986 -1.174 -10.549*** 
NUM_LEGISLATIONS 19,477 6.145 4607 8.201 -2.056 -38.862*** 
NUM_CLAIMS 19,477 15.370 4,607 17.608 -2.239 -13.798*** 
RENEWAL 19,477 9.995 4,607 10.786 -0.790 -11.145*** 
QUALITY_INDEX 19,475 0.234 4,605 0.287 -0.052 -28.542*** 
NUM_BACK_CIT 19,477 4.020 4,607 3.585 0.436 9.063*** 
NUM_NPL_CIT 19,477 1.395 4,607 2.252 -0.857 -21.666*** 
NUM_IPC_4_DIGIT 19,477 1.730 4,607 1.856 -0.126 -8.212*** 
Legend: * p<0.05, ** p<0.01, *** p<0.001 
Table 14. Test for equality of the mean (disclosed vs. controls) for the USPTO patents 
 Controls Disclosed   
Variable Obs. Mean Obs. Mean Diff t-stat 
NUM_FORW_CIT 56,100 22.296 12,832 41.202 -18.906 -42.309*** 
NUM_LEGISLATIONS 56100 4.029 12832 7.241 -3.212 -100.077*** 
NUM_CLAIMS 56,100 18.249 12,832 20.849 -2.600 -20.969*** 
RENEWAL 56,100 7.162 11,473 7.676 -0.514 -12.251*** 
QUALITY_INDEX 56,095 0.282 11,473 0.359 -0.077 -62.784*** 
NUM_BACK_CIT 56,100 19.856 12,832 18.907 0.949 3.313*** 
NUM_NPL_CIT 56,100 5.533 12,832 7.591 -2.058 -15.949*** 
NUM_IPC_4_DIGIT 56,100 2.025 12,832 2.137 -0.112 -10.786*** 
Legend: * p<0.05, ** p<0.01, *** p<0.001 
 
We observe two important things. Firstly, we see that for most variables, the sample means for the USPTO 
are different (often higher) than those for the EPO. This is related to institutional differences between 
these offices, like differences in the working procedures of the examiners, or the duties of applicants.62 
Secondly, within each of these offices, we see clear differences between disclosed patents and controls 
patents. In fact, for all the metrics used, except backward citations, disclosed patents have statistically 
significant higher average values. For instance, EPO disclosed patents receive on average 3.0 citations, 
whereas the EPO control group score of 1.8. Similarly, the USPTO disclosed patents receive on average 
                                                        
62  A good example here is the large difference in magnitude for the variables NUM_BACK_CIT and NUM_NPL_CIT. This is explained 
by the duty of candor at the USPTO. This duty obliges applicants at the USPTO to a more binding commitment in disclosing prior 
art, resulting in a larger number of backward citations reported in the USPTO document as compared to the EPO, and hence, by 
on average more received forward citations.  
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41.2 citations, whereas the USPTO control group receives 22.3. Both results suggest that disclosed patents 
have both a higher technical merit63 and a higher economic value.  
Regarding the number of countries in which applicants seek protection (variable NUM_LEGISLATIONS), EPO 
disclosed patents have on average a larger geographical scope as they are applied in 8.2 legislations, 
whereas the control group this is 6.1. We see a similar difference for the USPTO patents. Furthermore, 
both technological breadth measured using patent claims (NUM_CLAIMS) and length of patent validity 
measured with renewals (RENEWAL) are higher for disclosed patents than controls, both at the EPO and 
the USPTO. Finally, the composite index of patent quality we use (QUALITY_INDEX) also indicates that EPO 
and USPTO disclosed patents have higher quality than the control set. 
Backward citations (NUM_BACK_CIT) is the only variable where we see a lower score for disclosed patents 
compared with the control patents. While this result might look counterintuitive, it might be due to some 
form of strategic citing. Lampe (2012) shows that applicants with large patent portfolios in sectors such 
as computer and electronics strategically retain more known prior-art. Even if this study is not specifically 
related to standard-essential patents, we cannot exclude that this result on backward citations might be 
driven by strategic withholding.  
The above observations for differences between the averages is interesting, but taken in isolation, they 
may not tell the full story. Therefore, we also do a multivariate regression analysis, to control 
simultaneously for multiple patent characteristics. The regression specification we use is: 
𝑌𝑖 = 𝑓(𝛼 + 𝛽𝐷𝐸𝐶𝐿𝐴𝑅𝐸𝐷𝑖 + 𝛾𝑋𝑖 + 𝜆𝑡 + 𝜃𝑐 + 𝜀𝑖)       (1) 
where 𝑌𝑖 is a measure of quality for patent 𝑖 as: number of forward citations (NUM_FORW_CIT), number of 
legislations (NUM_LEGISLATIONS), number of claims (NUM_CLAIMS), number of years the patent is 
renewed (RENEWAL), and the composite index of quality (QUALITY_INDEX). The variable of primary interest 
for this analysis is dummy variable DISCLOSED that is equal to one if patent 𝑖 is disclosed essential to 
ETSI or there is a disclosed essential patent in its family (according to the ETSI definition), and 0 otherwise. 
Vector 𝑋𝑖 is a set of control variables that include number of backward citations (NUM_BACK_CIT), number 
of citations to previous scientific literature (NUM_NPL_CIT), number of 4-digit IPC classes reported in the 
patent (NUM_IPC_4_DIGIT), and a dummy variable equal to one if there is an earlier PCT international 
application (INTERNATIONAL_APPL). Finally, 𝜆𝑡  and 𝜃𝑐 are a set of filing year and technology class fixed-
effects, respectively. To unfold possible differences in quality that might emerge from institutional 
differences in the prosecution process, all these models are separately estimated for the EPO and USPTO 
patents. 
  
                                                        
63  Concerning technical merit, it is important to acknowledge that forward citations performance may also be a result of the fact 
that a patent is disclosed as potentially essential. Concerning economic value, this possible bias is less relevant, as the fact that 
a patent is potentially essential in fact can increase its economic value.  
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We estimate Equation 1 using an Ordinary Least Squares (OLS) model. However, as some of the 
dependent variables are count variables, we also employ a Poisson Quasi Maximum Likelihood (PQML) 
model to correct for potential overdispersion in our dependent variables.  
Table 15 and Table 16 report the descriptive statistics of the variables used in the regression analysis for 
the EPO and USPTO, respectively.  
Table 15. Summary statistics of the variables for the EPO patents 
Variable Observations Mean Std. Dev. Min Max 
NUM_FORW_CIT 24,084 2.037 6.808 0 194 
NUM_LEGISLATIONS 24,084 6.538 3.329 1 39 
RENEWAL 24,084 10.147 4.338 1 21 
QUALITY_INDEX 24,080 0.244 0.114 0.038 0.877 
DISCLOSED 24,084 0.191 0.393 0 1 
NUM_BACK_CIT 24,084 3.937 2.938 0 198 
NUM_NPL_CIT 24,084 1.559 2.438 0 123 
NUM_IPC_4_DIGIT 24,084 1.754 0.940 1 20 
NUM_CLAIMS 24,084 15.798 9.942 0 255 
INTERNATIONAL_APPL 24,084 0.739 0.439 0 1 
 
Table 16. Summary statistics of the variables for the USPTO patents 
Variable Observations Mean Std. Dev. Min Max 
NUM_FORW_CIT 68,932 25.815 46.254 0 2478 
NUM_LEGISLATIONS 68,932 4.627 3.511 1 43 
RENEWAL 67,573 7.249 4.098 0 21 
QUALITY_INDEX 67,568 0.296 0.123 0.022 0.949 
DISCLOSED 68,932 0.186 0.389 0 1 
NUM_BACK_CIT 68,932 19.679 29.261 0 3072 
NUM_NPL_CIT 68,932 5.916 13.209 0 917 
NUM_IPC_4_DIGIT 68,932 2.046 1.064 1 30 
NUM_CLAIMS 68,932 18.733 12.712 0 596 
INTERNATIONAL_APPL 68,932 0.365 0.482 0 1 
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Table 17 reports the estimates of our main coefficient of interest, 𝛽, in the case of forward citations. For 
all the estimation methods (OLS and PQML), the variable DISCLOSED is positive and highly significant. 
However, the magnitude of the coefficients of the two different methods cannot be directly compared, as 
they capture different aspects. In case of a positive sign, the OLS coefficient indicates the expected 
number of citations additionally received by disclosed patents. The coefficients column show that EPO 
disclosed patents have additionally 1.2 more citations than the EPO controls patents; whereas USPTO 
disclosed patents have additionally 19.6 more citations than the USPTO control patents (OLS). These 
numbers are consistent with the differences reported in Table 13 and Table 14. Poisson coefficients, in 
turn, can be translated into a percentage change by exponentiating and subtracting one. PQML coefficients 
are closer in magnitude, and indeed, while the effect is always larger at the USPTO, the percentage 
increases are more comparable being 68.9 percent for EPO and 88.9 percent for the USPTO.64  
Table 17. Number of forward citations regressions 
Dependent variable: NUM_FORW_CIT 
 EPO patents USPTO patents 
 OLS PQML OLS PQML 
DISCLOSED 1.175*** 
(0.14) 
0.518*** 
(0.05) 
19.628*** 
(0.55) 
0.636*** 
(0.01) 
NUM_BACK_CIT 0.107*** 
(0.02) 
0.064*** 
(0.01) 
0.062*** 
(0.02) 
0.001* 
(0.00) 
NUM_NPL_CIT 0.086*** 
(0.02) 
0.033*** 
(0.01) 
0.202*** 
(0.02) 
0.008*** 
(0.00) 
NUM_IPC_4_DIGIT 0.225*** 
(0.06) 
0.071*** 
(0.02) 
1.851*** 
(0.19) 
0.054*** 
(0.01) 
INTERNATIONAL_APPL -4.747*** 
(0.14) 
-1.997*** 
(0.04) 
-8.595*** 
(0.27) 
-0.433*** 
(0.01) 
CONSTANT -10.201*** 
(1.53) 
-2.015** 
(0.87) 
71.137 
(.) 
3.783*** 
(0.63) 
FILING YEAR DUMMY YES YES YES YES 
IPC DUMMY YES YES YES YES 
Observations 24084 24084 68932 68932 
Log-Likelihood  -66125.8  -1009494.9 
R-squared 0.178  0.226  
Note: OLS estimations with clustered standard errors reported in parenthesis. Poisson Quasi Maximum Likelihood (PQML) 
estimations with clustered standard errors. Legend: * p<0.05, ** p<0.01, *** p<0.001 
 
  
                                                        
64  These figures are obtained as exp(0.518)-1 and as exp(0.636)-1. 
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Table 18 presents the results when the outcome variable is the number of legislations. Also in this case, 
the coefficient of the variable DISCLOSED is positive and significant, indicating that disclosed patents are 
expected to have a larger geographic scope. In particular, ETSI families of EPO disclosed patents include 
2.0 more legislations than controls do, ETSI families of USPTO disclosed patents include 3.1 more 
legislations than controls do (OLS). The PQML outcomes confirm the results and indicate that ETSI family 
members of EPO and USPTO disclosed patents are filed in 32% and 74% more legislations than their 
controls, respectively. 
Table 18. Number of legislations regressions 
Dependent variable: NUM_LEGISLATIONS 
 EPO patents USPTO patents 
 OLS PQML OLS PQML 
DISCLOSED 2.001*** 
(0.06) 
0.280*** 
(0.01) 
3.061*** 
(0.04) 
0.556*** 
(0.01) 
NUM_BACK_CIT -0.062*** 
(0.01) 
-0.009*** 
(0.00) 
0.009*** 
(0.00) 
0.000 
(0.00) 
NUM_NPL_CIT -0.019** 
(0.01) 
-0.002 
(0.00) 
0.023*** 
(0.00) 
0.005*** 
(0.00) 
NUM_IPC_4_DIGIT 0.321*** 
(0.03) 
0.045*** 
(0.00) 
0.360*** 
(0.02) 
0.071*** 
(0.00) 
INTERNATIONAL_APPL 1.552*** 
(0.05) 
0.244*** 
(0.01) 
1.540*** 
(0.03) 
0.327*** 
(0.01) 
CONSTANT 5.314*** 
(1.63) 
2.033*** 
(0.20) 
4.168 
(1001.06) 
1.931*** 
(0.33) 
FILING YEAR DUMMY YES YES YES YES 
IPC DUMMY YES YES YES YES 
Observations 24084 24084 68932 68932 
Log-Likelihood 
 
-57658.5 
 
-170361.4 
R-squared 0.205 
 
0.228 
 Note: OLS estimations with clustered standard errors reported in parenthesis. Poisson Quasi Maximum Likelihood (PQML) 
estimations with clustered standard errors. Legend: * p<0.05, ** p<0.01, *** p<0.001 
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Table 19 shows the results for the technological scope of patents as measured by the number of claims. 
Also in this case, the variable DISCLOSED is positive and significant in all the estimated models. EPO 
disclosed patents have 2.4 additional claims (OLS), which is 15.6% more claims (PQML) than the patents 
in the control set. USPTO disclosed patents have 2.9 additional claims (OLS), which is 15.8% more claims 
(PQML) than the patents in the control set. 
Table 19. Number of claims regressions 
Dependent variable: NUM_CLAIMS 
 EPO patents USPTO patents 
 OLS PQML OLS PQML 
DISCLOSED 2.394*** 
(0.20) 
0.145*** 
(0.01) 
2.868*** 
(0.14) 
0.147*** 
(0.01) 
NUM_BACK_CIT 0.273*** 
(0.04) 
0.016*** 
(0.00) 
0.037*** 
(0.01) 
0.001*** 
(0.00) 
NUM_NPL_CIT 0.014 
(0.03) 
0.001 
(0.00) 
0.037*** 
(0.01) 
0.002*** 
(0.00) 
NUM_IPC_4_DIGIT 0.036 
(0.07) 
0.003 
(0.00) 
0.055 
(0.05) 
0.006** 
(0.00) 
INTERNATIONAL_APPL -0.278* 
(0.15) 
-0.017* 
(0.01) 
-4.793*** 
(0.10) 
-0.273*** 
(0.01) 
CONSTANT 3.134 
(2.75) 
1.867*** 
(0.38) 
8.498 
(.) 
2.213*** 
(0.26) 
FILING YEAR DUMMY YES YES YES YES 
IPC DUMMY YES YES YES YES 
Observations 24084 24084 68932 68932 
Log-Likelihood  -108301.4  -370286.3 
R-squared 0.0507  0.0728  
Note: OLS estimations with clustered standard errors reported in parenthesis. Poisson Quasi Maximum Likelihood (PQML) 
estimations with clustered standard errors. Legend: * p<0.05, ** p<0.01, *** p<0.001 
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Table 20 reports the estimates for the model where the outcome is the number of years in which the 
patent is valid on the basis of paid renewal fees. The coefficient of the variable DISCLOSED is positive and 
significant for all the specifications suggesting that disclosed patents have a longer active life. In 
particular, EPO disclosed patents are expected to last 0.94 year longer (OLS), which corresponds to a 9.5 
percent increase (PQML), as compared to controls. Regarding the USPTO disclosed patents, they are 
expected to last 0.26 year longer (OLS), that corresponds to a 3% increase, as compared to controls 
(PQML).  
Table 20. Number of renewals regressions  
Dependent variable: RENEWAL 
 EPO patents USPTO patents 
 OLS PQML OLS PQML 
DISCLOSED 0.944*** 
(0.03) 
0.091*** 
(0.00) 
0.225*** 
(0.01) 
0.030*** 
(0.00) 
NUM_BACK_CIT 0.029*** 
(0.01)0 
0.003*** 
(0.00) 
0.001*** 
(0.00) 
0.000*** 
(0.00) 
NUM_NPL_CIT 0.000 
(0.00) 
0.000 
(0.00) 
-0.000 
(0.00) 
-0.000 
(0.00) 
NUM_IPC_4_DIGIT 0.118*** 
(0.02) 
0.010*** 
(0.00) 
-0.010* 
(0.01) 
-0.002** 
(0.00) 
INTERNATIONAL_APPL 0.059 
(0.04) 
0.006* 
(0.00) 
0.128*** 
(0.01) 
0.021*** 
(0.00) 
CONSTANT 8.429*** 
(2.30) 
2.375*** 
(0.16) 
2.444 
(441.22) 
0.609*** 
(0.19) 
FILING YEAR DUMMY YES YES YES YES 
IPC DUMMY YES YES YES YES 
Observations 24084 24084 67573 67573 
Log-Likelihood  -53712.3  -132146.5 
R-squared 0.753  0.891  
Note: OLS estimations with clustered standard errors reported in parenthesis. Poisson Quasi Maximum Likelihood (PQML) 
estimations with clustered standard errors. Legend: * p<0.05, ** p<0.01, *** p<0.001 
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Table 21 reports the estimates for the model where the outcome is the OECD composite quality index 
indicator. While all previous dependent variables were count variables, this index indicator is a continuous 
variable. Therefore, we only estimate the OLS model. Furthermore, this indicator does not have a scale, so 
the interpretation of the coefficient is not straightforward. Still, the positive and significant coefficient 
indicates that both EPO and USPTO disclosed patents have higher quality index than the controls patents.  
Table 21. Quality composite index regressions 
Dependent variable: QUALITY_INDEX 
 EPO patents USPTO patents 
 OLS OLS 
DISCLOSED 0.050*** 
(0.00) 
0.071*** 
(0.00) 
NUM_BACK_CIT -0.001*** 
(0.00) 
0.001*** 
(0.00) 
NUM_NPL_CIT -0.000 
(0.00) 
0.001*** 
(0.00) 
NUM_IPC_4_DIGIT 0.017*** 
(0.00) 
0.020*** 
(0.00) 
INTERNATIONAL_APPL 0.004** 
(0.00) 
-0.016*** 
(0.00) 
CONSTANT 0.315*** 
(0.06) 
0.255*** 
(0.07) 
FILING YEAR DUMMY YES YES 
IPC DUMMY YES YES 
Observations 24080 67568 
R-squared 0.163 0.247 
Note: OLS estimations with clustered standard errors reported in parenthesis. Legend: * p<0.05, ** p<0.01, *** p<0.001 
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So far, our analyses have indicated that, irrespectively of the outcome variable used, disclosed patents 
score higher (i.e., are of higher quality) than control patents. In the remaining part of the report we further 
explore the presence of possible temporal patterns. Table 22 and Table 23 report the estimates for the 
number of forward citations for EPO and USPTO disclosed patents respectively, over three time-period 
starting in 1990.65 The number of additional expected citations for both the EPO and USPTO disclosed 
patents decrease over time from 2.89 to 0.21 and from 47.77 to 8.94, respectively. However, this 
decreasing trend might occur because patents recently filed have less time to accumulate citations and 
they might display a lower average number of citations. The PQML result seems to confirm this 
interpretation for the USPTO as its coefficient increases in the last period. The USPTO patents filed 
between 1990 and 1999 receive about 88.7% more forward citations than the random controls; whereas 
this percentage increases up to 103% for the USPTO patents filed between 2010 and 2017. However, for 
the EPO, the PQML estimation confirms the decrease also in terms of percentages. The EPO patents filed 
between 1990 and 1999 receive about 57.8% more forward citations than the random controls; whereas 
this percentage decrease to 46% for the EPO patents filed between 2010 and 2017. 
Table 22. Number of forward citations regressions over time for EPO 
Dependent variable: NUM_FORW_CIT 
 1990-1999 2000-2009 2010-2017 
 OLS PQML OLS PQML OLS PQML 
DISCLOSED 2.889*** 
(0.66) 
0.465*** 
(0.09) 
1.220*** 
(0.17) 
0.592*** 
(0.06) 
0.212*** 
(0.06) 
0.376*** 
(0.08) 
NUM_BACK_CIT 0.158* 
(0.08) 
0.040*** 
(0.02) 
0.128*** 
(0.02) 
0.076*** 
(0.01) 
0.029*** 
(0.01) 
0.061*** 
(0.01) 
NUM_NPL_CIT 0.236 
(0.16) 
0.036 
(0.02) 
0.100*** 
(0.03) 
0.032*** 
(0.01) 
0.021*** 
(0.01) 
0.034*** 
(0.01) 
NUM_IPC_4_DIGIT 0.498*** 
(0.19) 
0.080*** 
(0.03) 
0.089* 
(0.05) 
0.042* 
(0.02) 
0.069* 
(0.04) 
0.132** 
(0.06) 
INTERNATIONAL_APPL -10.086*** 
(0.50) 
-2.411*** 
(0.13) 
-4.132*** 
(0.15) 
-1.882*** 
(0.05) 
-1.450*** 
(0.12) 
-1.575*** 
(0.08) 
CONSTANT 7.985*** 
(1.58) 
1.054 
(0.66) 
4.169*** 
(0.44) 
-13.446 
(19.83) 
-0.940 
(0.85) 
-11.309*** 
(2.88) 
FILING YEAR DUMMY YES YES YES YES YES YES 
IPC DUMMY YES YES YES YES YES YES 
Observations 3518 3518 13016 13016 7350 7350 
Log-Likelihood  -17815.4  -37464.0  -8713.0 
R-squared 0.217  0.124  0.101  
Note: OLS estimations with clustered standard errors reported in parenthesis. Poisson Quasi Maximum Likelihood (PQML) 
estimations with clustered standard errors. Legend: * p<0.05, ** p<0.01, *** p<0.001 
 
 
                                                        
65  The 591 patents filed before 1990 are excluded from the analysis. 
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Table 23. Number of forward citations regressions over time for USPTO patents 
Dependent variable: NUM_FORW_CIT 
 1990-1999 2000-2009 2010-2017 
 OLS PQML OLS PQML OLS PQML 
DISCLOSED 47.768*** 
(3.73) 
0.635*** 
(0.04) 
22.425*** 
(0.76) 
0.598*** 
(0.02) 
8.938*** 
(0.34) 
0.711*** 
(0.02) 
NUM_BACK_CIT 0.602*** 
(0.14) 
0.006*** 
(0.00) 
0.114*** 
(0.02) 
0.002*** 
(0.00) 
-0.013 
(0.01) 
-0.002*** 
(0.00) 
NUM_NPL_CIT 1.031** 
(0.45) 
0.007** 
(0.00) 
0.260*** 
(0.03) 
0.006*** 
(0.00) 
0.163*** 
(0.02) 
0.011*** 
(0.00) 
NUM_IPC_4_DIGIT 7.750*** 
(1.18) 
0.107*** 
(0.01) 
1.111*** 
(0.22) 
0.030*** 
(0.01) 
0.423*** 
(0.12) 
0.036*** 
(0.01) 
INTERNATIONAL_APPL -21.013*** 
(2.42) 
-0.430*** 
(0.05) 
-10.458*** 
(0.45) 
-0.386*** 
(0.02) 
-5.362*** 
(0.22) 
-0.526*** 
(0.02) 
CONSTANT 15.020 
(33.28) 
3.542*** 
(0.46) 
33.271* 
(17.43) 
3.469*** 
(0.44) 
12.807*** 
(3.15) 
2.384*** 
(0.37) 
FILING YEAR DUMMY YES YES YES YES YES YES 
IPC DUMMY YES YES YES YES YES YES 
Observations 6722 6722 32613 32613 29206 29206 
Log-Likelihood  -203364.4  -545814.0  -228853.9 
R-squared 0.157  0.159  0.160  
Note: OLS estimations with clustered standard errors reported in parenthesis. Poisson Quasi Maximum Likelihood (PQML) 
estimations with clustered standard errors. Legend: * p<0.05, ** p<0.01, *** p<0.001 
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The estimations carried out using the OECD composite quality index are reported in Table 24, and indicate 
contrasting results. For the EPO patents, the coefficient of the variable DISCLOSED decreases in the 
second period and increases again for the period between 2010 and 2017. The last increase is rather 
small as compared to the decrease, so we can conclude that the overall quality of disclosed EPO patents 
does not increase over time. The results for the USPTO are more evident and they indicate that on average 
the quality of USPTO disclosed patents decreased over time. 
Table 24. Quality composite index regressions over time for EPO and the USPTO 
Dependent variable: QUALITY_INDEX     
 EPO    USPTO   
 1990-
1999 
2000-
2009 
2010-
2017 
 1990-
1999 
2000-
2009 
2010-
2017 
 OLS OLS OLS  OLS OLS OLS 
DISCLOSED 0.080*** 
(0.01) 
0.043*** 
(0.00) 
0.046*** 
(0.00) 
 0.112*** 
(0.00) 
0.080*** 
(0.00) 
0.046*** 
(0.00) 
NUM_BACK_CIT 0.004*** 
(0.00) 
-0.001*** 
(0.00) 
-0.001*** 
(0.00) 
 0.002*** 
(0.00) 
0.001*** 
(0.00) 
0.000 
(0.00) 
NUM_NPL_CIT -0.000 
(0.00) 
-0.000 
(0.00) 
0.000 
(0.00) 
 0.001** 
(0.00) 
0.001*** 
(0.00) 
0.001*** 
(0.00) 
NUM_IPC_4_DIGIT 0.027*** 
(0.00) 
0.018*** 
(0.00) 
0.003* 
(0.00) 
 0.029*** 
(0.00) 
0.017*** 
(0.00) 
0.022*** 
(0.00) 
INTERNATIONAL_APPL 0.013*** 
(0.00) 
0.001 
(0.00) 
0.003 
(0.00) 
 0.024*** 
(0.00) 
-0.009*** 
(0.00) 
-0.026*** 
(0.00) 
CONSTANT 0.263*** 
(0.05) 
0.177*** 
(0.01) 
0.354*** 
(0.07) 
 0.314*** 
(0.07) 
0.301*** 
(0.06) 
0.200*** 
(0.03) 
FILING YEAR DUMMY YES YES YES  YES YES YES 
IPC DUMMY YES YES YES  YES YES YES 
Observations 3518 13016 7350  6713 32549 27915 
R-squared 0.192 0.0931 0.296  0.277 0.251 0.177 
Note: OLS estimations with clustered standard errors reported in parenthesis. Legend: * p<0.05, ** p<0.01, *** p<0.001 
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To conclude, all the analyses we carried out to assess the quality of patents disclosed as SEPS relative to 
the sample of suitable controls, point in the same direction. Disclosed SEPs score higher in terms of all the 
main proxies for patent quality that are commonly used in the patent literature. This is true for both those 
variables usually associated with technical merit (the technological contribution to the field) and those 
variables usually associated with economic value (the economic returns that a patent generates).  
All in all, these results confirm the expectation that patents disclosed to ETSI are of greater technological 
importance and have more market potential than suitable controls.  
That disclosed SEPs have a higher technical merit may indicate that SDOs are able to attract promising 
technologies (to know whether they are able to include attractive technologies, we would need to know 
which of these are factually essential). Yet, the higher technical merit may also be the result of the act of 
disclosure as such. Firstly, disclosed patents are more ‘visible’. Secondly, for any party investing in R&D in 
a technical field where standards are important, it is rational to build such R&D upon knowledge already 
embedded in these standards, instead of on a ‘dead track’. This also increases the likelihood that essential 
patents, and also the wider set of disclosed, potentially essential patents, receive more citations from 
future patents. 
That disclosed SEPs on average have a higher economic value than comparable, not disclosed patents is 
not surprising. After all, a subset of these patents will become factually essential patents, will then need to 
be licensed by all parties in the world that implement that standard,66 and thus have the potential to 
generate significant licensing revenues (or other benefits such as cross-licensing opportunities). Hence, it is 
rational for applications of such patents to seek protection in many countries and renew their patent, 
which are exactly the variables that are associated with higher economic value of a patent.  
 
                                                        
66  To be precise: insofar the product implementation is in a product category that requires the essential patent, and it is not only 
essential for an optional feature that is not implemented in the product implementation. 
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5 Summary and conclusions  
The main goals of this study are (a) to provide a patent landscape analysis of SDO disclosed patents (and 
what this implies for their use as input to an essentiality assessment mechanism), and (b) to analyse 
whether SDO disclosed patents differ from comparable other patents in quality (both technical merit and 
economic value).  
Our main conclusions are as follows:  
 While the ETSI IPR database of disclosed potentially standard-essential patents is by far the most 
sophisticated one, it is a non-trivial task to identify patents from that database and 
clean/harmonize/select/de-duplicate/transform that data into information to be used for a given 
purpose, such as input for a process of essentiality assessment. Also important is a good 
understanding of both the ETSI IPR policy, the related procedures, and database aspects. In 
particular, a good understanding of the meaning of a ‘patent family’ in the ETSI context is 
important. For good reasons, ETSI uses a tailor-made definition for this concept, and this has 
significant impact on understanding and interpreting the data for specific purposes. Unlike usual 
definitions of patent families such as DOCDB and INPADOC, ETSI patent families are ego-families 
and not mutually exclusive. As a simplified example, Figure 28 shows how a given set of eight 
patents and their priority relations translate into two DOCDB patent families, one INPADOC 
family, and eight ETSI patent families (which partly overlap).  
While the ETSI database also contains a large number of ‘non-harmonized records’ (i.e., records 
that ETSI itself has not yet managed to match with the EPO patent database), we found that 
these records are not likely to have a large impact on the use of the data.  
Figure 28. Differences between patent family definitions, for a given set of patents  
and their associated priorities (for details and colour coding, see Section 2.2)   
 
Six DOCDB families: one with patent C and D, one with patent 
G and H, and all other patents a one member family.  
 
One INPADOC family. 
 
Illustration of the ETSI family definition  
of the disclosed (‘basis’) patent C. 
 
Seven families following the ETSI family definition. Note that 
these are ego-families (as seem from one specific patent). 
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 Data on disclosed patents provides valuable insights into which patents are potentially essential 
to a standard. This data clearly serves an important aspect within the operation in SDO itself, 
namely, to ensure that a standard only requires known patented inventions for which a FRAND 
commitment has been issued. It is important, however, to be well aware of the intrinsic 
limitations of such data if used for other purposes. Among other things, patents disclosed as 
being potentially essential (1) may not be owned (anymore) by the disclosing firm, (2) may not be 
factually essential (3) may not be granted, (4) may not be enforceable (valid, non-expired, 
renewal fees paid, etc.), (5) may greatly differ in technical merit, (6) may relate to functionalities 
not relevant for a certain product category (e.g., a mobile phone or an infrastructure product), and 
(7) may relate to optional features that might not be used in a given device conforming to the 
standard. Moreover, the patent families of these patents may differ substantially in terms of 
geographical coverage.  
 
 ETSI-disclosed patents can be used as a starting point for an essentiality assessment procedure 
Overall, the dataset includes 25,070 disclosed patent families, of which 16,089 contain an EPO 
patent (Table 25 left column, second plus third row, also shown in Figure 29). Focusing on 
disclosed patent families whose basis patent was granted as of February 2019 yields a much 
lower total of 12,760 families, among them 9,818 with an EPO family member (Table 25, middle 
column). If one limits the assessment procedure to SEP exposure in Europe (i.e. only looks at 
patent families that comprise a granted EPO patent), then the relevant dataset includes 8,320 
EPO patents that would need to be investigated: 1,449 families that have a granted EPO patent 
as a basis patent, and for 6,871 families there is a granted EPO patent in the family of the 
disclosed basis (Table 25, right column). It is worth noting that those 2,942 patent families whose 
basis patent is granted but that do not contain an EPO patent are mostly filed at the Chinese 
patent office and at the WIPO. Numbers could go down a bit if one excludes expired patents from 
the analysis, as well as patents that cannot be enforced because renewal fees have not been 
paid. But doing so requires careful consideration whether there are family members of that 
patent that are still alive, which would result in enforceability (and thus SEP exposure) in other 
geographies. Further note that these were the numbers as of February 201967 and, almost on a 
daily basis, new patents are disclosed, and patents that were disclosed earlier in time, are 
granted. 
 
Table 25. Number of disclosed patent families (following the ETSI family definition): total, with granted basis patent 
and with granted EPO patent.  
Patent families Total number With granted  
basis patent 
With granted  
EPO patent 
Total number of disclosed families (patent families 
following the ETSI family definition) 
25,072 (100%) 12,760 (100%) 8,320 (100%) 
 which have an EPO basis patent  2,151 (8.6%) 1,449 (11.4%) 1,449 (17.4%) 
 which do not have an EPO basis patent but 
include an EPO family member 
13,938 (55.6%) 8,369 (65.6%) 6,871 (82.6%) 
 which do not have an EPO basis patent and do not 
have an EPO family member 
8,983 (35.8%) 2,942 (23.1%) n/a 
 
                                                        
67  These numbers are based on the ETSI database as of late February 2019 (when we retrieved that data), and patent grant 
information is from the PATSTAT 2018 Autumn Edition. 
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Figure 29. Number of disclosed patent families (following the ETSI family definition):  
total, with granted basis patent and with granted EPO patent. 
 
 
 For the 6,871 families where there is a granted EPO patent in the family of the (non-EPO) 
disclosed basis patent, it is key that the ETSI patent family definition is used to identify that EPO 
patent. If the DOCDB family definition were used instead, changes are significant that no EPO 
patent is identified at all while there may very well exist a factually, EPO family member of the 
disclosed patent. If the INPADOC family definition were used, changes are significant that an EPO 
patent is selected which is factually non-essential, while another EPO family member exists that 
is factually essential (bot not selected).  
 
 There is considerable variety over time in the number of new patent families being disclosed. In 
general, the trend us upwards (see Figure 8, above, for more details). In the years 2017 and 2018 
alone, 9,311 new patent families were disclosed to ETSI – that is 37% of the total of all 
25,072 families (the year 2019 falls mostly outside our data set). This is a clear peak compared 
to other years, most likely because of intense 5G standardization activity during that period. 
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 There is considerable fragmentation in the distribution of companies – or organisations – that 
disclosed these patents, as shown in Figure 30. Furthermore, the distribution is skewed, with a 
long tail: out of the 148 disclosing firms, 14 disclosed more than 500 patent families, 
21 companies disclosed between 50 and 500 families, and 113 disclosed less than 50 families. 
Again, we emphasize that the current owners of these patents may be different from the 
disclosing firms. These distributional characteristics are relevant in case any essentiality scheme 
chooses to use sampling: given the skewed nature of the distribution, a sample of disclosed 
patents might need to be stratified in order to be representative of individual firms. Assessing 
larger samples or even full portfolios for such companies is a potential solution.  
Figure 30. Number of disclosed patent families (following the ETSI family definition) by  
earliest disclosing company; shown for the 35 largest companies; full time period (1990-2019).  
(data set: the 25,072 disclosed basis patents, coming from different jurisdictions) 
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 We observe big shifts over time in terms of the home country of firms disclosing patents (see 
Figure 31 and Section 3.5, above, for more details). Especially remarkable is the recent increase in 
shares of disclosed patent families from Chinese firms and, to a lesser degree, from South 
Korean firms, at the expense of European and US firms. Again, we stress that such numbers as 
such do not say yet anything about whether these patents will eventually be granted (and in 
which countries), what their technical merit is, etc. But the growth in numbers is notable. This is 
also reflected by an increasing share of disclosed basis patents from the Chinese patent office 
(see Section 3.6 for details). 
Figure 31. Share of disclosed patent families (following the ETSI family definition) by home country/region of 
disclosing firm, over time (data set: the 25,072 disclosed basis patents, coming from different jurisdictions).  
 
Note: the 1990-1996 time frame is omitted in this picture, as there are few observations in that time slot. 
 It would be desirable to break ETSI disclosures related to cellular standards up into, for instance, 
technology generations (2G, 3G, 4G and 5G). Yet, despite the high sophistication of the ETSI 
disclosure database, for the bulk of the ETSI disclosures, such a distinction cannot be made in a 
reliable way without examining the content of each individual disclosed patent. This is related, 
among other things, to the way 3GPP technical specifications series are structured (see Section 
2.7 for details). 
 
 This study also investigated whether SDO disclosed patents differ in quality from comparable 
other patents. In this context, we looked at two dimensions of quality: technical merit (i.e., the 
technological contribution to the field) and economic value (i.e., the economic returns that a 
patent generates). We use observable characteristics of patents and patent families, such as 
forward citations, family size, and patent renewal, to proxy both dimensions. While such proxies 
are known to be far from perfect, they still do provide us with valuable insights. Our analyses find 
that disclosed SEPs score higher in terms of all the main proxies for patent quality that are 
commonly used in the patent literature. This is true for both those variables usually associated 
with technical merit and those variables usually associated with economic value. All in all, these 
results confirm the expectation that patents disclosed to ETSI are of greater technological 
importance and have more market potential than suitable controls.  
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Our interpretation of these findings is as follows: 
 That disclosed patents have a higher economic value than comparable, non-disclosed 
patents is not surprising. After all, a subset of these patents will become factually 
essential patents, will then need to be licensed by all parties in the world that implement 
that standard,68 and thus have the potential to generate significant licensing revenues 
(or other benefits such as cross-licensing opportunities). Hence, it is rational for 
applicants of such patents to seek protection in many countries and renew their patents, 
which are exactly the variables that are associated with higher economic value of a 
patent.  
 That disclosed patents have a higher technical merit may indicate that SDOs are able to 
attract attractive technologies (to know whether they are able to select attractive 
technologies for the standard, we would need to know which of these are factually 
essential). Yet, the higher technical merit may also be the result of the act of disclosure 
as such. Firstly, disclosed patents are more ‘visible’. Secondly, for any party investing in 
R&D in a technical field where standards are important, it is rational to build such R&D 
upon knowledge already embedded in these standards, instead of on a ‘dead track’. This 
also increases the likelihood that essential patents (and also the wider set of disclosed, 
potentially essential patents) receive more citations from future patents. 
  
 
                                                        
68  To be precise: insofar the product implementation is in a product category that requires the essential patent, and it is not only 
essential for an optional feature that is not implemented in the product implementation.  
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Appendix 1: Name harmonization for disclosing firms  
For purposes of readability, we removed indications to legal forms such as “Inc.”; “Corporation”, “Ltd.”, “GmbH”, 
etc., from the firm names. In some cases, we added (for instance, ‘IRT’ was changed in ‘IRT (Institut für 
Rundfunktechnik).69 
Sometimes, companies have used different names when disclosing patents to ETSI (different spellings, legal 
entities from different countries, names of full subsidiaries). Where we believed this was the case, we brought 
these entries together. We also did so when a company changed name in its entirety (e.g. ‘Research in Motion’ 
who renamed itself into ‘Blackberry’). Table 26 shows when we merged two or more names of disclosing 
entities.  
Note, however, that our starting point was the name as provided at the time of disclosure, and we did not 
bring entries together that may have been part of mergers or acquisitions (M&A’s), that went bankrupt and 
assets transferred to new owners, or cases where patent ownership of parts of full portfolios was transferred, 
or otherwise. Such an exercise falls out of the scope of our study. (Names of merged entities may appear in 
our data, however, when firms themselves used these names when they submitted disclosures. For instance, 
our database has separate names for “AT&T”, “Lucent”, “Alcatel”, “Alcatel-Lucent” and “Nokia”, where all of 
these entities was part of M&A’s.)  
Table 26. Overview of merged company names  
Short name Original disclosure name 
Alcatel-Lucent 'ALU', 'ALU', 'ALCATEL-LUCENT', 'ALU PARENT', 'ALU-ALU Shanghai Bell', 'Alcatel-Lucent Deutschland AG', 
'ALU USA', 'Alcatel-Lucent Shanghai Bell', 'ALU US', 'ALU and ALU-ALU Shanghai Bell Co. Ltd’ 
Apple 'Apple Inc.', 'Apple (UK) Limited’ 
AT&T 'AT&T', 'AT&T Intellectual Property II, LLC’ 
Blackberry 'Research in Motion Limited' ,'BlackBerry UK Limited' ,'BlackBerry LTD 
Dolby Laboratories 'Dolby Laboratories Inc.', 'Dolby Laboratories, Inc.’ 
Ericsson 'Ericsson', 'ERICSSON MOBILE COMMUNICATIONS’ 
Huawei 'Huawei', 'Huawei Technologies Co. Ltd.', 'Huawei Technologies Co., Ltd.’ 
INFINEON 'INFINEON TECHNOLOGIES', 'Infineon Technologies Flash’ 
Innovative Sonic 'Innovative Sonic Ltd.', 'Innovative Sonic Corp.’ 
InterDigital 'InterDigital Technology Corp.', 'InterDigital Patent Holdings', 'InterDigital Patent Holdings, Inc.', 'InterDigital 
Technology Corporation', 'IPR Licensing Inc.', 'IPR Licensing, Inc.', 'ITC', 'IDPA Holdings, Inc.' 
KPN 'KPN N.V.', 'Koninklijke KPN N.V.’ 
Mitsubishi Electric 'Mitsubishi Electric RCE', 'Mitsubishi Electric Info', 'Mitsubishi Electric Corp', 'Mitsubishi Electric Telecom’ 
Motorola 'Motorola Mobility Inc.', 'MOTOROLA Inc’, ‘MML’ 
Nokia 'Nokia Corporation', 'Nokia Technologies Oy', 'Nokia Networks Oy', 'Nokia Networks', 'NOKIA MOBILE PHONES', 
'Nokia Shanghai Bell’, ‘NOA’ 
Orange 'ORANGE', 'Orange Personal Communications’ 
Panasonic 'Panasonic Mobile Communication', 'Panasonic Corporation’ 
Qualcomm 'Qualcomm Incorporated', 'QUALCOMM Inc', 'Qualcomm Atheros,  Inc.’ 
Blackberry 'Research in Motion Limited', 'BlackBerry UK Limited', 'BlackBerry LTD’ 
Siemens 'Siemens AG', 'Siemens Aktiengesellschaft’ 
Sony 'Sony United Kingdom Ltd', 'Sony Corporation’ 
Texas Instruments 'Texas Instruments Inc.', 'TEXAS Instruments’ 
Vodafone 'Vodafone IP Licensing Limited', 'VODAFONE LTD’ 
Note: sometimes multiple original disclosure names look almost identical, but there is a different comma, period or space in the name. 
                                                        
69  This added information is primarily based on the online ISDL forms the firms submitted to ETSI, and the underlying facsimile 
documents, which often offer additional information on the name of the company.  
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Appendix 2: Companies by total number of disclosed patent families 
Table 27. Companies by total number of disclosed patent families (following the ETSI family definition). See also the disclaimers show in Figure 14. 
Disclosing firm 1990
-
1999 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Total 
Huawei 
      
66 54 19 45 322 80 594 151 149 175 101 122 402 727 366 3373 
Qualcomm 
  
154 
 
1 43 7 96 68 92 161 211 138 151 52 104 96 184 181 624 
 
2363 
Samsung 
    
75 
  
46 17 99 88 53 230 155 131 260 141 26 365 523 
 
2209 
Nokia 27 24 160 106 65 45 85 67 70 124 205 130 113 86 134 144 127 87 62 342 
 
2203 
LG Electronics 7 
      
2 
  
237 23 119 159 1 219 85 163 832 95 
 
1942 
ZTE  
           
70 82 
 
391 
 
208 51 11 1103 3 1919 
Ericsson 37 
 
2 119 
 
86 56 3 1 
 
114 142 40 59 97 91 161 102 294 72 
 
1476 
CATT 
            
258 
  
94 19 
 
130 685 
 
1186 
Intel 
            
7 11 1 35 6 73 694 96 
 
923 
InterDigital 
  
13 
  
86 
  
65 120 35 106 56 28 65 42 20 35 17 
  
688 
Sharp 
            
7 55 49 50 
  
347 128 
 
636 
NTT DOCOMO 
         
49 71 76 48 22 70 44 27 56 122 38 
 
623 
Motorola 40 6 3 60 37 4 2 9 
 
1 27 256 
 
70 81 
      
596 
ETRI 
    
6 
    
1 30 
 
26 1 17 13 46 8 321 12 
 
481 
NEC  3 
    
41 
    
11 1 34 93 15 19 31 29 37 17 
 
331 
Panasonic 
      
40 12 
  
33 46 5 
 
81 
 
85 
  
24 
 
326 
Alcatel-Lucent 
        
1 5 11 10 24 7 21 24 9 19 50 115 
 
296 
Blackberry 
   
2 
   
1 14 2 5 20 13 43 37 37 6 19 13 15 2 229 
Sony 
          
25 2 
   
63 34 38 17 49 
 
228 
Apple 
        
13 
   
22 93 19 20 16 23 14 8 
 
228 
OPPO 
                  
2 212 
 
214 
Siemens 2 1 25 8 22 4 11 28 23 7 13 
 
7 4 2 14 13 9 13 2 
 
208 
Texas Instruments 
      
6 1 
 
30 
  
43 71 29 
 
22 
    
202 
Kyocera 
             
10 67 
  
108 
   
185 
HTC 
            
24 41 23 
  
27 
 
44 
 
159 
Fujitsu 
      
2 
          
93 64 
  
159 
Innovative Sonic 
   
17 
  
12 
     
80 
 
13 
    
20 
 
142 
Philips 16 
   
45 
     
21 1 7 
  
39 
   
12 
 
141 
KT Corp. 
               
17 
 
46 
 
62 
 
125 
MediaTek                               12   40   40   92 
Nokia Siemens Networks (NSN)                                     20 53   73 
Fraunhofer IIS                 2                 58 1 7   68 
Alcatel 25 2   23 6 1 3 1                           61 
Nortel Networks     1 1   7 5   2 31 1 5 7                 60 
Pantech                           41 13 5           59 
(continued on the next page) 
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Disclosing firm 1990
-
1999 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Total 
ITRI   2                           15     18 17   52 
Orange   2   1   3 5   2 3   2 4 7 6 4 2         41 
Microsoft         1                   33             34 
Mitsubishi Electric 6     2 14                 12               34 
Dolby Laboratories           24                       9       33 
KPN 1   2   2     1   2   1   3 2 4 4 5 1 3   31 
Telia  29                                         29 
Toshiba            21                   4 2         27 
General Dynamics                7 3         16               26 
Convida                                     26     26 
ASUSTeK        5       1                       19   25 
IDAC Holdings                                     22     22 
Unwired Planet                             14 1 3   3     21 
Hughes Network Systems         19                                 19 
Renesas                           6 12             18 
VoiceAge      2     1           1           14       18 
Thomson                               16     1     17 
Marvell                       7     9             16 
Deutsche Telekom 1           1   5   3     1     4         15 
Evolium       3     10 1                           14 
ITL (Innovative Technology Lab)                                       13   13 
INFINEON           3   1   9                       13 
Freescale Semiconductor                       7 5                 12 
Sun Patent Trust                                       12   12 
Inmarsat       3                         9         12 
Sierra Wireless                           1       1 4 5   11 
Hanyang University                               6   5       11 
CP8 Technologies 10                                         10 
Optis Wireless Technology                               5 4   1     10 
OpenTV                         10                 10 
AirTouch Communications 10                                         10 
SKT                           6     3     1   10 
Other 81 firms 19 16 6 11 13 2 9 10 12 16 7 5 9 2 11 10 7 20 21 10 0 216 
Totals 233 53 368 361 306 371 320 341 317 636 1420 1255 2012 1405 1645 1586 1291 1470 4106 5205 371 25072 
 
Notes: This table shows all firms with 10 or more disclosed patent families (following the ETSI family definition). Data for other firms are aggregated and shown at the bottom of the table. For two of the 
25,072 patent families, the earliest disclosure was dated “1900”. Assuming this is an error, we changed that to 1990, the earliest date of other patents in the disclosure database.  
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